Category,FY,Funding IC,Project Number,Sub Project #,Project Title,PI Name,Org Name,State / Country,Amount
Lymphoma,2016,NCI,5R01CA154739-05,,Targeting Slc16a/Mct Lactate Transporters in Cancer Therapeutics,"CLEVELAND, JOHN",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$598,617"
Lymphoma,2016,NCI,1K22CA197014-01,,Analysis and Therapeutic Targeting Non-proteolytic Protein Ubiquitination in Diffuse Large B Cell Lymphoma,"YANG, YIBIN",RESEARCH INST OF FOX CHASE CAN CTR,PA,"$194,616"
Lymphoma,2016,NIAID,5R01AI105114-03,,Viral Interface with an Interferon-Induced Gene,"REICH, NANCY",STATE UNIVERSITY NEW YORK STONY BROOK,NY,"$463,541"
Lymphoma,2016,NIAID,5R01AI072194-07,,Elucidation of Immunoglobulin Class Switch Recombination,"CHAUDHURI, JAYANTA",SLOAN-KETTERING INST CAN RESEARCH,NY,"$439,750"
Lymphoma,2016,NIAID,5R21AI111125-02,,Role of PRMT5 in HTLV-1 transformation and disease,"GREEN, PATRICK",OHIO STATE UNIVERSITY,OH,"$231,000"
Lymphoma,2016,NIAID,5R01AI114557-02,,Neutralizing Antibodies in Acute and Persistent Epstein-Barr Virus Infection,"WANG, FREDERICK",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$612,662"
Lymphoma,2016,NIAID,5R01AI114556-02,,"Targeting Fnip1 to disrupt B cell development, metabolism, and transformation","IRITANI, BRIAN",UNIVERSITY OF WASHINGTON,WA,"$395,376"
Lymphoma,2016,NCI,5R01CA182461-03,,Defining the impact of clonal evolution on chronic lymphocytic leukemia,"WU, CATHERINE",DANA-FARBER CANCER INST,MA,"$362,378"
Lymphoma,2016,NIDCR,4R01DE022291-05,,KSHV infection of human tonsillar B cells,"KEDES, DEAN",UNIVERSITY OF VIRGINIA,VA,"$385,000"
Lymphoma,2016,NCI,4R37CA076584-18,,F-box proteins: deregulated cell cycle control and proteolysis in cancer,"PAGANO, MICHELE",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$446,546"
Lymphoma,2016,NCI,4R01CA085180-15,,Epstein-Barr Virus LMP1-Mediated Oncogenecity,"KIEFF, ELLIOTT",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$762,316"
Lymphoma,2016,NCI,4R01CA164178-04,,A novel NKG2D-specific BiTE cancer immunotherapy,"SENTMAN, CHARLES",DARTMOUTH COLLEGE,NH,"$336,150"
Lymphoma,2016,NCI,5R21CA191726-02,,Therapeutic targeting of the B-cell lymphoma associated mutation MYD88-L265P,"SNYDER, GREG",UNIVERSITY OF MARYLAND BALTIMORE,MD,"$179,403"
Lymphoma,2016,NCI,4P30CA006516-51,6047,Lymphoma and Myeloma,"SHIPP, MARGARET",DANA-FARBER CANCER INST,MA,"$93,216"
Lymphoma,2016,NCI,5R01CA184187-02,,DNA-PKCS Phosphorylation in DNA Repair and Chromosomal Translocations,"ZHA, SHAN",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$366,000"
Lymphoma,2016,NCI,5R21CA184707-02,,Genomic instability mediated via differential DNA repair mechanisms in B cells,"WANG, JING",UNIVERSITY OF COLORADO DENVER,CO,"$202,928"
Lymphoma,2016,NCI,4R01CA134674-07,,GENETIC EPIDEMIOLOGY OF CHRONIC LYMPHOCYTIC LEUKEMIA,"CAMP, NICOLA",UNIVERSITY OF UTAH,UT,"$557,717"
Lymphoma,2016,NCI,4R01CA166450-04,,Characterizing tumor suppressive functions of microRNAs in B-cell neoplasia,"RAO, DINESH",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$319,550"
Lymphoma,2016,NCI,4R01CA168482-04,,HIV-driven B cell activation: role in the genesis of AIDS-related lymphoma,"MARTINEZ-MAZA, OTONIEL",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$319,550"
Lymphoma,2016,NCI,4F31CA183569-03,,The Role of ATF4 in Promoting c-Myc Induced Lymphomagenesis,"TAMEIRE, FEVEN",UNIVERSITY OF PENNSYLVANIA,PA,"$43,120"
Lymphoma,2016,NCI,4R01CA172492-04,,Role of MLL2 Gene Inactivation in B cell Non Hodgkin Lymphoma,"PASQUALUCCI, LAURA",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$332,000"
Lymphoma,2016,NIAID,4R01AI106393-04,,BH3-only protein targeting by HHV-8,"NICHOLAS, JOHN",JOHNS HOPKINS UNIVERSITY,MD,"$405,000"
Lymphoma,2016,NCI,5P30CA008748-50,7551,Monoclonal Antibody,"WEIS-GARCIA, FRANCES",SLOAN-KETTERING INST CAN RESEARCH,NY,"$282,755"
Lymphoma,2016,NIGMS,5R01GM111741-02,,High-throughput informatics for antibodies,"MACCARTHY, THOMAS",STATE UNIVERSITY NEW YORK STONY BROOK,NY,"$266,488"
Lymphoma,2016,NCI,5K22CA184308-02,,Dissecting Genetic and Epigenetic variation in the Cancer Regulome,"HODGES, EMILY",VANDERBILT UNIVERSITY,TN,"$157,854"
Lymphoma,2016,NCI,4R01CA165206-05,,CD19 Directed CAR Therapy,"JUNE, CARL",UNIVERSITY OF PENNSYLVANIA,PA,"$237,659"
Lymphoma,2016,NIAID,5R01AI108407-02,,Role of MHV68 miRNAs in latencyand pathogenesis,"TIBBETTS, SCOTT",UNIVERSITY OF FLORIDA,FL,"$390,515"
Lymphoma,2016,NCI,4R01CA172582-04,,Alpha Radioimmunotherapy for Lymphoma Treatment,"SANDMAIER, BRENDA",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$634,846"
Lymphoma,2016,NCI,5R01CA183444-03,,Molecular Evaluation of Targeted Therapies in Lymphoid Malignancies,"BYRD, JOHN",OHIO STATE UNIVERSITY,OH,"$536,570"
Lymphoma,2016,NCI,4P50CA094056-16,7927,Imaging NFkB Activation in HTLV Lymphoma,"RATNER, LEE",WASHINGTON UNIVERSITY,MO,"$101,413"
Lymphoma,2016,NCI,5R01CA172724-02,,Novel Strategies to Target Leukemia-Stromal Interactions,"HUANG, PENG",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$366,000"
Lymphoma,2016,NCI,1R35CA200422-01,,Molecular Basis of KSHV oncogenesis,"JUNG, JAE",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$652,549"
Lymphoma,2016,NIAID,5R01AI106676-03,,Epstein Barr virus antisense transcription,"FLEMINGTON, ERIK",TULANE UNIVERSITY OF LOUISIANA,LA,"$376,250"
Lymphoma,2016,NIAID,4R01AI018757-34,,Host Immunity to EBV Infection in Vitro and in Vivo,"THORLEY-LAWSON, DAVID",TUFTS UNIVERSITY BOSTON,MA,"$412,500"
Lymphoma,2016,NIDCR,5K99DE024969-02,,Factors Influencing KSHV Infection and Spread within the Oral Cavity,"TOTONCHY, JENNIFER",WEILL MEDICAL COLL OF CORNELL UNIV,NY,"$123,050"
Lymphoma,2016,NIAID,5R21AI112602-02,,Chromosome fragility and translocations in lymphocytes,"ROBBIANI, DAVIDE",ROCKEFELLER UNIVERSITY,NY,"$254,250"
Lymphoma,2016,NCI,1P50CA192937-01A1,7606,Administrative Core,"YOUNES, ANAS",SLOAN-KETTERING INST CAN RESEARCH,NY,"$245,228"
Lymphoma,2016,NCI,1P50CA192937-01A1,7607,BIOSPECIMENS CORE,"DOGAN, AHMET",SLOAN-KETTERING INST CAN RESEARCH,NY,"$221,023"
Lymphoma,2016,NCI,1P50CA192937-01A1,7608,BIOSTATISTICS AND BIOINFORMATICS CORE,"SESHAN, VENKATRAMAN",SLOAN-KETTERING INST CAN RESEARCH,NY,"$182,764"
Lymphoma,2016,NCI,1P50CA192937-01A1,7609,DEVELOPMENTAL RESEARCH PROGRAM,"YOUNES, ANAS",SLOAN-KETTERING INST CAN RESEARCH,NY,"$224,278"
Lymphoma,2016,NCI,1P50CA192937-01A1,7611,Development of Mechanism-Based Therapy For Myc+/Bcl2+ Diffuse Large B Cell Lymphoma,"YOUNES, ANAS",SLOAN-KETTERING INST CAN RESEARCH,NY,"$275,717"
Lymphoma,2016,NCI,1P50CA192937-01A1,7612,Autologous CD19 Targeted 19-28z+ Tcells for the Treatment of Relapsed Diffuse Large B cell Lymphoma in Transplant Ineligible Elderly Patients,"BRENTJENS, RENIER",SLOAN-KETTERING INST CAN RESEARCH,NY,"$313,752"
Lymphoma,2016,NCI,1P50CA192937-01A1,7613,Translating Stress Response Targeted Therapy for B-Cell Lymphomas,"CHIOSIS, GABRIELA",SLOAN-KETTERING INST CAN RESEARCH,NY,"$317,872"
Lymphoma,2016,NCI,1P50CA192937-01A1,7614,Targeting Acetyltransferase Gene Inactivation in Diffuse Large B Cell Lymphoma,"ZELENETZ, ANDREW",SLOAN-KETTERING INST CAN RESEARCH,NY,"$381,366"
Lymphoma,2016,NCI,4R01CA165469-04,,Role of Tcl1 and Par-4 in regulation of chronic lymphocytic leukemia,"BONDADA, SUBBARAO",UNIVERSITY OF KENTUCKY,KY,"$381,420"
Lymphoma,2016,NCI,4R01CA091791-14,,Reactivation of Kaposi's Sarcoma-Associated Herpesvirus,"SUN, REN",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$284,547"
Lymphoma,2016,NCI,5R01CA180758-03,,KSHV interactions with host inflammasome components,"CHANDRAN, BALA",ROSALIND FRANKLIN UNIV OF MEDICINE & SCI,IL,"$320,588"
Lymphoma,2016,NIAID,5R37AI037526-22,,Class Switch Recombination in B Lymphocytes,"NUSSENZWEIG, MICHEL",ROCKEFELLER UNIVERSITY,NY,"$423,750"
Lymphoma,2016,NCI,5R01CA076167-13,,Genetic Analysis of Myeloproliferative Disease,"COWELL, JOHN",GEORGIA REGENTS UNIVERSITY,GA,"$307,800"
Lymphoma,2016,NCI,5R01CA180813-03,,Kaposi's Sarcoma-associated Herpesvirus Mimics of Cellular microRNAs,"GOTTWEIN, EVA",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$320,588"
Lymphoma,2016,NCI,2P30CA016520-40,8007,Hematologic Malignancies Research Program,"STADTMAUER, EDWARD",UNIVERSITY OF PENNSYLVANIA,PA,"$72,887"
Lymphoma,2016,NCI,2P30CA016520-40,4005,Melanoma and Cutaneous Malignancies Research Program,"SCHUCHTER, LYNN",UNIVERSITY OF PENNSYLVANIA,PA,"$72,887"
Lymphoma,2016,NCI,4R01CA119917-09,,Studying the role of KSHV-encoded miRNAs,"RENNE, ROLF",UNIVERSITY OF FLORIDA,FL,"$301,913"
Lymphoma,2016,NCI,4R01CA157660-05,,The Role of NF-kB in B-Cell Differentiation and Lymphomagenesis,"KLEIN, ULF",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$331,433"
Lymphoma,2016,NCI,2P30CA014089-41,8288,Molecular Genetics Research Program (Project-001),"LIEBER, MICHAEL",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$35,512"
Lymphoma,2016,NCI,2P30CA016086-40,8627,EARLY PHASE CLINICAL RESEARCH SUPPORT (Core 020),"DEES, ELIZABETH",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$283,606"
Lymphoma,2016,NIEHS,4R01ES021832-04,,Endocrine disrupter modulation of SXR in development and lymphomagenesis,"BLUMBERG, BRUCE",UNIVERSITY OF CALIFORNIA-IRVINE,CA,"$422,908"
Lymphoma,2016,NCI,4R01CA164605-05,,Hdac3 as a therapeutic target in BCL6-dependent lymphoma,"HIEBERT, SCOTT",VANDERBILT UNIVERSITY,TN,"$403,135"
Lymphoma,2016,NCI,4R01CA166144-05,,Development of Therapeutic CD59 inhibitor for treating B-cell malignancies,"QIN, XUEBIN",TEMPLE UNIV OF THE COMMONWEALTH,PA,"$327,938"
Lymphoma,2016,NCI,4UM1CA173642-04,,Women's Health Initiative Cancer Survivor Cohort,"ANDERSON, GARNET",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$2,396,733"
Lymphoma,2016,NCI,5R01CA190384-02,,The genomic pathogenesis of Follicular Lymphoma,"MALEK, SAMI",UNIVERSITY OF MICHIGAN,MI,"$541,994"
Lymphoma,2016,NIAID,4U01AI104342-04,,Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children,"ESQUIVEL, CARLOS",STANFORD UNIVERSITY,CA,"$1,363,549"
Lymphoma,2016,NCI,4P01CA094237-14,7520,VACCINATION TO ENHANCE T CELL IMMUNOTHERAPY,"HESLOP, HELEN",BAYLOR COLLEGE OF MEDICINE,TX,"$295,517"
Lymphoma,2016,NCI,5R01CA179363-03,,Molecular signature of inflammation,"MALARKANNAN, SUBRAMANIAM",MEDICAL COLLEGE OF WISCONSIN,WI,"$322,594"
Lymphoma,2016,NIDCR,5R01DE025208-02,,KSHV latent infection replication,"KAYE, KENNETH",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$443,750"
Lymphoma,2016,NIGMS,1K99GM117302-01,,A novel role for 53BP1 independent of damage that controls chromatin structure,"PEREIRA DA ROCHA, PEDRO",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$90,000"
Lymphoma,2016,NCI,5R01CA075922-20,,Rhesus HHV-8 homologue in AIDS-related malignancies,"WONG, SCOTT",OREGON HEALTH & SCIENCE UNIVERSITY,OR,"$748,902"
Lymphoma,2016,NCI,5R01CA187299-02,,Epigenetic Gene Regulation by JAK1 Kinase in Diffuse Large B-Cell Lymphoma,"RUI, LIXIN",UNIVERSITY OF WISCONSIN-MADISON,WI,"$349,988"
Lymphoma,2016,NCI,5F31CA192835-02,,Intratumoral Heterogeneity and Tumor Evolution in Lymphoma,"KASTENHUBER, EDWARD",SLOAN-KETTERING INST CAN RESEARCH,NY,"$43,576"
Lymphoma,2016,NIAID,5R01AI110328-03,,Viral Long Noncoding RNA Functions in Epstein-Barr Virus Infection,"SAMPLE, JEFFERY",PENNSYLVANIA STATE UNIV HERSHEY MED CTR,PA,"$378,297"
Lymphoma,2016,NCI,4R01CA170023-04,,Roles of Epstein-Barr virus nuclear antigens 2 and LP in B cell proliferation,"KIEFF, ELLIOTT",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$393,163"
Lymphoma,2016,NCI,5R01CA184384-03,,Prognostic Metabolic Signatures of Cancers Through Mass Spectrometry Imaging,"FELSHER, DEAN",STANFORD UNIVERSITY,CA,"$528,101"
Lymphoma,2016,NIAID,1R21AI122068-01,,Antibody-based prophylactic EBV vaccine,"SNAPPER, CLIFFORD",HENRY M. JACKSON FDN FOR THE ADV MIL/MED,MD,"$231,012"
Lymphoma,2016,NCI,5K22CA188106-02,,Characterization of replication-mediated DNA damage in B lymphocytes,"BARLOW, JACQUELINE",UNIVERSITY OF CALIFORNIA AT DAVIS,CA,"$162,000"
Lymphoma,2016,NCI,1R01CA193140-01A1,,Targeting the Ig-light chains with CAR-T cells in lymphoid tumors,"DOTTI, GIANPIETRO",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$569,255"
Lymphoma,2016,NIAID,5U19AI109965-03,5822,Innate Recognition of Human Herpesviruses,"DAMANIA, BLOSSOM",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$415,378"
Lymphoma,2016,NCI,4R01CA160256-05,,Temporal and Spatial Control of V(D)J Recombination,"DESIDERIO, STEPHEN",JOHNS HOPKINS UNIVERSITY,MD,"$336,150"
Lymphoma,2016,NCI,4R01CA164152-05,,Role of acetyltransferase gene inactivation in follicular lymphoma pathogenesis,"DALLA-FAVERA, RICCARDO",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$332,000"
Lymphoma,2016,NCI,4R01CA177319-04,,The Role of NOTCH1 in the Pathogenesis of CLL.,"DALLA-FAVERA, RICCARDO",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$358,315"
Lymphoma,2016,NCI,5R21CA185930-02,,Function-blocking anti-ADAM protease antibodies for inhibition of tumorigenesis,"NIKOLOV, DIMITAR",SLOAN-KETTERING INST CAN RESEARCH,NY,"$191,291"
Lymphoma,2016,NCI,1R01CA195732-01A1,,The Role of MMSET in the Pathogenesis and Progression of Lymphoid Malignancy,"LICHT, JONATHAN",UNIVERSITY OF FLORIDA,FL,"$343,125"
Lymphoma,2016,NCI,1R21CA202525-01,,Targeting CXCR5 for angioimmunoblastic T-cell lymphoma,"LOLIS, ELIAS",YALE UNIVERSITY,CT,"$212,223"
Lymphoma,2016,NCI,5F30CA189433-02,,Investigating the function of MTBP in lymphoma,"PUCCETTI, MATTHEW",VANDERBILT UNIVERSITY,TN,"$28,234"
Lymphoma,2016,NCI,5R01CA137488-21,,Two Compartment Models to Improve Brain Tumor Therapy,"NEUWELT, EDWARD",OREGON HEALTH & SCIENCE UNIVERSITY,OR,"$474,976"
Lymphoma,2016,NCI,4R01CA124332-10,,Regulation of KSHV infection and replication by MAPK pathways,"GAO, SHOU-JIANG",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$304,095"
Lymphoma,2016,NCI,1UH2CA202637-01,,Smartphone for molecular cancer diagnostic in Africa,"WEISSLEDER, RALPH",MASSACHUSETTS GENERAL HOSPITAL,MA,"$491,375"
Lymphoma,2016,NIAID,4R01AI058057-12,,Function of the Gamma HV68 M2 Antigen,"SPECK, SAMUEL",EMORY UNIVERSITY,GA,"$385,800"
Lymphoma,2016,NCI,4R01CA154674-06,,Cotranslational Functions of MTOR,"JACINTO, ESTELA",RBHS-ROBERT WOOD JOHNSON MEDICAL SCHOOL,NJ,"$328,265"
Lymphoma,2016,NCI,5R01CA142698-07,,Molecular mechanism and relevance of microRNAs in DSB repair pathway choice,"CHOWDHURY, DIPANJAN",DANA-FARBER CANCER INST,MA,"$409,002"
Lymphoma,2016,NHLBI,4R01HL116452-04,,The role of the SF3B1 splicing factor in chronic lymphocytic leukemia,"WU, CATHERINE",DANA-FARBER CANCER INST,MA,"$434,621"
Lymphoma,2016,NCI,5P01CA174653-03,6841,The Role of CTIP in Lymphocyte Development and Lymphomagenesis,"ZHA, SHAN",COLUMBIA UNIVERSITY,NY,"$364,328"
Lymphoma,2016,NCI,5P01CA174653-03,6845,Pathology,"BHAGAT, GOVIND",COLUMBIA UNIVERSITY,NY,"$188,901"
Lymphoma,2016,NCI,5U01CA183012-03,,Stem Cell Gene Therapy Following R-EPOCH for Non-Hodgkin Lymphoma in AIDS Patient,"ZAIA, JOHN",BECKMAN RESEARCH INSTITUTE/CITY OF HOPE,CA,"$106,075"
Lymphoma,2016,NCI,4R01CA063417-16,,PROLIFERATIVE EFFECTS OF HTLV-1,"RATNER, LEE",WASHINGTON UNIVERSITY,MO,"$158,641"
Lymphoma,2016,NCI,4R01CA113809-10,,Role of Missing Metastasis Gene in tumor progression,"ZHAN, STEVEN",UNIVERSITY OF MARYLAND BALTIMORE,MD,"$264,562"
Lymphoma,2016,NCI,4R01CA158323-05,,Studies of Lymphoma Suppression and DNA Repair,"DU, CHUNYING",UNIVERSITY OF CINCINNATI,OH,"$325,775"
Lymphoma,2016,NCI,4R01CA070723-19,,Genetic Analysis of EBV's Immortalizing Genes,"SUGDEN, WILLIAM",UNIVERSITY OF WISCONSIN-MADISON,WI,"$291,588"
Lymphoma,2016,NCI,4R01CA174462-04,,New Models and Treatments for AIDS-related Lymphoma,"KENNEY, SHANNON",UNIVERSITY OF WISCONSIN-MADISON,WI,"$416,873"
Lymphoma,2016,NIAID,4R01AI076183-14,,Structural and Functional Studies of gp42 and HLA Class 2 in EBV Entry,"LONGNECKER, RICHARD",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$507,585"
Lymphoma,2016,NCI,5F31CA196209-02,,Examining the Role of Rho Kinase in the Pathogenesis of ABC-DLBCL,"RICKER, EDD",WEILL MEDICAL COLL OF CORNELL UNIV,NY,"$43,576"
Lymphoma,2016,NIAID,4R01AI101046-05,,Intercellular communication in Epstein Barr virus reactivation,"FLEMINGTON, ERIK",TULANE UNIVERSITY OF LOUISIANA,LA,"$376,250"
Lymphoma,2016,NCI,4R01CA162411-04,,Novel monocyte effector function in CLL immune therapy,"TRIDANDAPANI, SUSHEELA",OHIO STATE UNIVERSITY,OH,"$319,550"
Lymphoma,2016,NCI,5R01CA192267-02,,Monitoring disease progression in follicular lymphoma with next-gen sequencing,"CARLSON, CHRISTOPHER",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$691,364"
Lymphoma,2016,NCI,4R01CA166219-05,,Molecular epidemiology of non-Hodgkin lymphoma prognosis and prevention,"WANG, SOPHIA",BECKMAN RESEARCH INSTITUTE/CITY OF HOPE,CA,"$561,758"
Lymphoma,2016,NCI,4R01CA174794-04,,Brain Integrity in Survivors of Childhood Cancer Treated with Thoracic Radiation,"KRULL, KEVIN",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$642,665"
Lymphoma,2016,NCI,5R21CA195173-02,,The genetics of hepatosplenic T cell lymphoma,"DAVE, SANDEEP",DUKE UNIVERSITY,NC,"$180,599"
Lymphoma,2016,NCI,5R00CA151827-05,,Role of Replication Stress during Myc-dependent Lymphomagenesis,"DOMINGUEZ-SOLA, DAVID",ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI,NY,"$238,992"
Lymphoma,2016,NCI,5R01CA167093-06,,Myc-directed control of mRNA turnover in lymphopoiesis and lymphomagenesis,"CLEVELAND, JOHN",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$349,638"
Lymphoma,2016,NCI,5F30CA183520-02,,Targeting CD37 and elucidating its role in B-cell malignancy,"BECKWITH, KYLE",OHIO STATE UNIVERSITY,OH,"$38,671"
Lymphoma,2016,NCI,1R01CA194263-01A1,,Understanding Psychosocial and Immunologic Responses in Indolent Lymphoproliferative Disorders,"FANG, CAROLYN",RESEARCH INST OF FOX CHASE CAN CTR,PA,"$662,485"
Lymphoma,2016,NCI,5R01CA193655-02,,Defining the Functional Role of Mutations in Diffuse Large B cell Lymphoma,"DAVE, SANDEEP",DUKE UNIVERSITY,NC,"$510,478"
Lymphoma,2016,NHLBI,4R01HL116217-04,,Engraftment and in vivo selection of HIV-protected stem cells,"KIEM, HANS-PETER",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$808,300"
Lymphoma,2016,NCI,5R01CA184728-02,,Targeting Granzyme B to Separate GVH from GVL Responses,"CAO, XUEFANG",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$401,456"
Lymphoma,2016,NCI,4R01CA166325-05,,Mechanisms promoting translocations and mature B cell lymphomas,"WANG, JING",UNIVERSITY OF COLORADO DENVER,CO,"$333,570"
Lymphoma,2016,NCI,5R01CA188561-02,,The Tumor Suppressor Function of Dnmt3a in Chronic Lymphocytic Leukemia,"OPAVSKY, RENE",UNIVERSITY OF NEBRASKA MEDICAL CENTER,NE,"$344,269"
Lymphoma,2016,NCI,4R01CA177292-04,,Targeted Therapy for Lymphoid Malignancies,"BYRD, JOHN",OHIO STATE UNIVERSITY,OH,"$536,708"
Lymphoma,2016,NCI,4R01CA093606-14,,Regulation of EBV Latency by EBNA1,"LIEBERMAN, PAUL",WISTAR INSTITUTE,PA,"$329,956"
Lymphoma,2016,NIAID,1R43AI122529-01,,CRISPR-based anti-viral therapeutics to eliminate EBV-associated post-transplant lymphoproliferative disease,"XIONG, XIN",AGENOVIR CORPORATION,CA,"$149,972"
Lymphoma,2016,NCI,2R44CA153474-02A1,,Virus-targeted therapeutic for EBV-Associated Malignancies,"PERRINE, SUSAN","PHOENICIA BIOSCIENCES, INC.",MA,"$472,008"
Lymphoma,2016,NCI,7R21CA184352-02,,Myc-induced pathways in B cell lymphoma initiation and survival,"EISCHEN, CHRISTINE",THOMAS JEFFERSON UNIVERSITY,PA,"$169,650"
Lymphoma,2016,NCI,1F32CA203217-01,,Role of branched-chain amino catabolism in lymphopoiesis and lymphomagenesis,"FERNANDEZ, MARIO",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$58,002"
Lymphoma,2016,NCI,1F30CA203292-01,,"Chromatin dysregulation generated by recurrent point mutation in histone methyltransferase, MMSET, drives progression of lymphoid malignancies","SWAROOP, ALOK",UNIVERSITY OF FLORIDA,FL,"$37,411"
Lymphoma,2016,NCI,5R01CA182947-03,,Inhibition of PGE2 for mobilization of autologous peripheral blood stem cells,"FARAG, SHERIF",INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS,IN,"$321,933"
Lymphoma,2016,NCI,5R44CA192576-02,,A Phase IIa Study of rHuIL-12 as an Immunotherapy and Radiomitigator for CTCL Patients Receiving Radiotherapy,"BASILE, LENA","NEUMEDICINES, INC.",CA,"$417,175"
Lymphoma,2016,NCI,2R13CA124293-09,,Annual International Primary CNS Lymphoma Collaborative Group Meeting,"BATCHELOR, TRACY",MASSACHUSETTS GENERAL HOSPITAL,MA,"$2,500"
Lymphoma,2016,NIAID,5R01AI109644-03,,Differential mechanisms for RORgammat-regulated thymocyte development and Th17 di,"SUN, ZUOMING",BECKMAN RESEARCH INSTITUTE/CITY OF HOPE,CA,"$420,000"
Lymphoma,2016,NCI,4R01CA164641-04,,Natural Killer Cell Regulation by PRDM1 and IRF4/8,"WRIGHT, KENNETH",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$314,674"
Lymphoma,2016,NCI,5F31CA183551-02,,Mechanisms and Function of Suppressed RAG Expression by DNA Double Strand Breaks,"FISHER, MEGAN",UNIVERSITY OF PENNSYLVANIA,PA,"$43,576"
Lymphoma,2016,NIAID,1R21AI122670-01,,Developing a new model for EBV-mediated T cell diseases,"PELANDA, ROBERTA",UNIVERSITY OF COLORADO DENVER,CO,"$194,375"
Lymphoma,2016,NIDCR,1R01DE025804-01,,Role of IKK epsilon in KSHV/HHV8 associated malignancies,"CHAUDHARY, PREET",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$412,500"
Lymphoma,2016,NCI,4K23CA154874-04,,Optimization of adoptive immunotherapy with autologous CD20-specific T cells,"TILL, BRIAN",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$171,720"
Lymphoma,2016,NCI,5R01CA178453-03,,Role of MEF2B mutations in lymphomagenesis,"DALLA-FAVERA, RICCARDO",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$443,555"
Lymphoma,2016,NCI,5R01CA183876-03,,Towards The Chemotherapy-Free Treatment of Follicular Lymphoma,"WENDEL, HANS-GUIDO",SLOAN-KETTERING INST CAN RESEARCH,NY,"$475,801"
Lymphoma,2016,NCI,5R01CA184922-03,,(PQD1) lmpact of cytotoxic and targeted therapy on clonal evolution of CLL,"WU, CATHERINE",DANA-FARBER CANCER INST,MA,"$553,684"
Lymphoma,2016,NCI,4R01CA166741-05,,Anticancer drug-induced BH3-only protein.Bak interactions,"KAUFMANN, SCOTT",MAYO CLINIC ROCHESTER,MN,"$329,925"
Lymphoma,2016,NCI,4R01CA177600-04,,Regulation of CARD11 signaling in normal and dysregulated lymphocyte development,"POMERANTZ, JOEL",JOHNS HOPKINS UNIVERSITY,MD,"$336,150"
Lymphoma,2016,NCI,5R01CA187415-02,,MYC as a Biomarker in Aggressive Non-Hodgkin Lymphoma,"LI, YONG",CLEVELAND CLINIC LERNER COM-CWRU,OH,"$439,795"
Lymphoma,2016,NCI,5R01CA192928-02,,Dual targeting of XPO1 and BTK in B cell malignancies,"LAPALOMBELLA, ROSA",OHIO STATE UNIVERSITY,OH,"$445,083"
Lymphoma,2016,NCI,5UM1CA182934-02,,The NYU Women's Health Study,"ZELENIUCH-JACQUOTTE, ANNE",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$742,259"
Lymphoma,2016,NCI,4P01CA022443-39,6859,Controlling the Latent-to-Lytic Switch in Epstein-Barr Virus,"MERTZ, JANET",UNIVERSITY OF WISCONSIN-MADISON,WI,"$345,175"
Lymphoma,2016,NCI,4P01CA022443-39,6863,miRNA and v-Cdks: Independent Drivers OF EBV and HCMV Replication and Oncogenesi,"KENNEY, SHANNON",UNIVERSITY OF WISCONSIN-MADISON,WI,"$392,338"
Lymphoma,2016,NCI,5R01CA186775-03,,Development of a Small Molecule Inhibitor for KSHV LANA,"LIEBERMAN, PAUL",WISTAR INSTITUTE,PA,"$394,250"
Lymphoma,2016,NIGMS,5R01GM110052-03,,Functional roles of lipids in early B cell receptor signaling.,"VEATCH, SARAH",UNIVERSITY OF MICHIGAN,MI,"$288,288"
Lymphoma,2016,NCI,5F30CA183263-02,,Multifunctional polymeric carriers for the intracellular delivery of protein cancer therapeutics,"KERN, HANNA",UNIVERSITY OF WASHINGTON,WA,"$37,627"
Lymphoma,2016,NIAID,4R01AI105000-04,,KSHV Lytic DNA Replication and its Control Mechanism,"VERMA, SUBHASH",UNIVERSITY OF NEVADA RENO,NV,"$356,575"
Lymphoma,2016,NCI,5R21CA192854-02,,The coding genome of HIV-associated plasmablastic lymphomas in South Africa,"WILLEM, PASCALE","WITS HEALTH CONSORTIUM (PTY), LTD",SO AFR,"$182,178"
Lymphoma,2016,NIAID,5R21AI119894-02,,Analysis of the role of immune deficiency in E2A-/- T cell lymphomagenesis,"KEE, BARBARA",UNIVERSITY OF CHICAGO,IL,"$227,372"
Lymphoma,2016,NIAID,5R21AI118606-02,,Isolation of Regulators of Immune Cell Behavior,"POMERANTZ, JOEL",JOHNS HOPKINS UNIVERSITY,MD,"$202,500"
Lymphoma,2016,NCI,4U01CA168426-05,,Systems Biology of Tumor Progression and Drug Resistance,"CALIFANO, ANDREA",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$1,238,106"
Lymphoma,2016,NCI,5R01CA188286-02,,SEQUENCE-SPECIFIC CHROMATIN MODIFIERS; NOVEL PROTEIN THERAPEUTICS FOR B CELL LYMPHOMA,"PAYTON, JACQUELINE",WASHINGTON UNIVERSITY,MO,"$348,844"
Lymphoma,2016,NCI,5F30CA196082-02,,Defining the role of mutant XPO1 in chronic lymphocytic leukemia,"HING, ZACHARY",OHIO STATE UNIVERSITY,OH,"$38,311"
Lymphoma,2016,NCI,5R21CA189703-02,,Clinicopathological significance of PDLIM2 in HIV/AIDS-related malignancies caused by KSHV,"QU, ZHAOXIA",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$200,970"
Lymphoma,2016,NCI,4R01CA129037-09,,Replicative Senescence as a Tumor Suppressive Mechanism,"CHANG, SANDY",YALE UNIVERSITY,CT,"$306,860"
Lymphoma,2016,NCI,4R01CA159296-05,,Novel Immunotherapies for Lymphoid Malignancies,"BYRD, JOHN",OHIO STATE UNIVERSITY,OH,"$316,438"
Lymphoma,2016,NCI,5R01CA181699-03,,Investigating the roles of lncRNAs in cancer and development,"VENTURA, ANDREA",SLOAN-KETTERING INST CAN RESEARCH,NY,"$427,270"
Lymphoma,2016,NCI,5R01CA073507-18,,In Vivo Model of Epstein-Barr Virus Latency,"LONGNECKER, RICHARD",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$372,677"
Lymphoma,2016,NCI,7R01CA170006-05,,Microvesicle Dynamics in B-Cell Chronic Lymphocytic Leukemia Tumor Microenvironme,"GHOSH, ASISH",UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR,OK,"$305,069"
Lymphoma,2016,NCI,1R21CA200420-01A1,,The effect of statins on B cell dysfunction in HIV infection,"MARTINEZ-MAZA, OTONIEL",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$179,988"
Lymphoma,2016,NCI,1R01CA196266-01A1,,A Novel Strategy Targeting TfR1 for the Prevention/Treatment of AIDS-related NHL,"PENICHET, MANUEL",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$504,843"
Lymphoma,2016,NIAID,4R01AI067968-10,,Role and mechanism of action of gamma herpesvirus microRNAs,"CULLEN, BRYAN",DUKE UNIVERSITY,NC,"$392,500"
Lymphoma,2016,NCI,1R01CA192970-01A1,,Lipoxins and aspirin triggered lipoxins in KSHV latency and pathogenesis,"SHARMA-WALIA, NEELAM",ROSALIND FRANKLIN UNIV OF MEDICINE & SCI,IL,"$356,850"
Lymphoma,2016,NIDCR,1R01DE025567-01A1,,Atomic structure of Kaposi's sarcoma-associated herpesvirus capsid,"ZHOU, Z",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$385,000"
Lymphoma,2016,NCI,5R01CA181319-03,,Targeting Stem-Cell Dependent Drug Resistance in Human MCL,"MCCARTY, NAMI",UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON,TX,"$313,723"
Lymphoma,2016,NIGMS,4R01GM103843-04,,Dissecting Cell Signaling Mediated by Protein-Protein Interactions in Membranes,"YIN, HANG",UNIVERSITY OF COLORADO,CO,"$295,850"
Lymphoma,2016,NIGMS,4R01GM107058-04,,Role of constitutive androstane receptor in cyclophosphamide-based chemotherapy,"WANG, HONGBING",UNIVERSITY OF MARYLAND BALTIMORE,MD,"$291,650"
Lymphoma,2016,NCI,4R01CA047006-29,,Epstein-Barr Virus Nuclear Protein in B Cell Growth Transformation,"KIEFF, ELLIOTT",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$565,231"
Lymphoma,2016,NIGMS,1R35GM118009-01,,Site-Specific Recombination in Human Health & Disease,"LIEBER, MICHAEL",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$336,183"
Lymphoma,2016,NCI,4P01CA023766-37,6334,Clinical Trials Evaluating Transplant Strategies and Adoptive Cell Therapies to,"O'REILLY, RICHARD",SLOAN-KETTERING INST CAN RESEARCH,NY,"$433,106"
Lymphoma,2016,NCI,2R44CA144104-04,,Arrayed drug microinjection for guiding precision medicine in relapsed lymphoma,"KLINGHOFFER, RICHARD","PRESAGE BIOSCIENCES, INC.",WA,"$1,053,521"
Lymphoma,2016,NCI,5R01CA182905-03,,Protein-coding and non-coding RNA biomarkers for early detection of CLL,"CALIN, GEORGE",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$574,442"
Lymphoma,2016,NCI,5K24CA184039-03,,Molecularly Targeted Therapy for Lymphoma,"GOPAL, AJAY",UNIVERSITY OF WASHINGTON,WA,"$173,074"
Lymphoma,2016,NCI,4R01CA085563-14,,"ROS, Redox Regulation and Novel Targets for Cancer Therapy","HUANG, PENG",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$233,579"
Lymphoma,2016,NCI,4R01CA168558-05,,Cyclin requirements in gammaherpesvirus infection and disease,"VAN DYK, LINDA",UNIVERSITY OF COLORADO DENVER,CO,"$308,843"
Lymphoma,2016,NCI,5R01CA187040-04,,Targeting SIRT1 in Mantle Cell Lymphoma,"SETO, EDWARD",GEORGE WASHINGTON UNIVERSITY,DC,"$213,099"
Lymphoma,2016,NHLBI,4U10HL108945-06,,Anti-viral and antileukemic T-cell therapy as prophylaxis after HSCT,"HESLOP, HELEN",BAYLOR COLLEGE OF MEDICINE,TX,"$160,218"
Lymphoma,2016,NHLBI,4U10HL109322-06,,The Ohio State Blood and Marrow Transplant Reseach Consortium,"DEVINE, STEVEN",OHIO STATE UNIVERSITY,OH,"$151,193"
Lymphoma,2016,NCI,4P30AI027757-29,7315,HIV-Associated Malignancies (HIVAM),"HOLMES, KING",UNIVERSITY OF WASHINGTON,WA,"$52,079"
Lymphoma,2016,NHLBI,4P30AI027757-29,7315,HIV-Associated Malignancies (HIVAM),"HOLMES, KING",UNIVERSITY OF WASHINGTON,WA,"$37,284"
Lymphoma,2016,NIA,4P30AI027757-29,7315,HIV-Associated Malignancies (HIVAM),"HOLMES, KING",UNIVERSITY OF WASHINGTON,WA,"$2,683"
Lymphoma,2016,NIAID,4P30AI027757-29,7315,HIV-Associated Malignancies (HIVAM),"HOLMES, KING",UNIVERSITY OF WASHINGTON,WA,"$220,407"
Lymphoma,2016,NICHD,4P30AI027757-29,7315,HIV-Associated Malignancies (HIVAM),"HOLMES, KING",UNIVERSITY OF WASHINGTON,WA,"$11,008"
Lymphoma,2016,NIDA,4P30AI027757-29,7315,HIV-Associated Malignancies (HIVAM),"HOLMES, KING",UNIVERSITY OF WASHINGTON,WA,"$26,434"
Lymphoma,2016,NIDDK,4P30AI027757-29,7315,HIV-Associated Malignancies (HIVAM),"HOLMES, KING",UNIVERSITY OF WASHINGTON,WA,"$9,643"
Lymphoma,2016,NIGMS,4P30AI027757-29,7315,HIV-Associated Malignancies (HIVAM),"HOLMES, KING",UNIVERSITY OF WASHINGTON,WA,"$9,643"
Lymphoma,2016,NIMH,4P30AI027757-29,7315,HIV-Associated Malignancies (HIVAM),"HOLMES, KING",UNIVERSITY OF WASHINGTON,WA,"$28,586"
Lymphoma,2016,NIAID,4U19AI107810-04,8686,Study of Novel HHV8/KSHV Encoded Genes,"DAMANIA, BLOSSOM",UNIVERSITY OF NORTH CAROLINA SYSTEM,NC,"$401,899"
Lymphoma,2016,NCI,5R01CA193624-02,,Development of a Novel Inducer for EBV Lytic Therapy,"LIEBERMAN, PAUL",WISTAR INSTITUTE,PA,"$546,954"
Lymphoma,2016,NHLBI,4U10HL069233-16,,Nebraska/Kansas Blood and Marrow Transplant Research Network,"VOSE, JULIE",UNIVERSITY OF NEBRASKA MEDICAL CENTER,NE,"$154,372"
Lymphoma,2016,NCI,5P30CA023100-30,6336,Hematologic Malignancies,"LIPPMAN, SCOTT",UNIVERSITY OF CALIFORNIA SAN DIEGO,CA,"$21,082"
Lymphoma,2016,NCI,5R01CA134451-07,,Computer-based assessment of tumor microenvironment (TME) in Follicular Lymphoma,"GURCAN, METIN",OHIO STATE UNIVERSITY,OH,"$234,254"
Lymphoma,2016,NCI,5U01CA194389-02,,Modeling the Molecular Determinants of Induced Anti-Tumor Immune Responses in Mantle Cell Lymphoma,"ALIZADEH, ARASH",STANFORD UNIVERSITY,CA,"$638,806"
Lymphoma,2016,NCI,5R01CA193541-02,,Predicting Clinical Outcome After Traditional and Ibrutinib-based Therapy In Chronic Lymphocytic Leukemia,"SHANAFELT, TAIT",MAYO CLINIC ROCHESTER,MN,"$511,603"
Lymphoma,2016,NCI,4P01CA049605-27,5891,Immune Regulation in HCT,"NEGRIN, ROBERT",STANFORD UNIVERSITY,CA,"$1,151,707"
Lymphoma,2016,NCI,4P01CA049605-27,5892,Auto-lmmunotransplantation for Lymphoma,"LEVY, RONALD",STANFORD UNIVERSITY,CA,"$199,530"
Lymphoma,2016,NCI,4P01CA049605-27,5893,Memory CDS T Cells for GVL,"STROBER, SAMUEL",STANFORD UNIVERSITY,CA,"$150,528"
Lymphoma,2016,NCI,4P01CA049605-27,5894,Improving Graft-versus-Leukemia Alloimmunity against CLL,"MIKLOS, DAVID",STANFORD UNIVERSITY,CA,"$135,776"
Lymphoma,2016,NCI,4P01CA049605-27,5897,Administration and Clinical Trial Coordination,"NEGRIN, ROBERT",STANFORD UNIVERSITY,CA,"$258,742"
Lymphoma,2016,NCI,4P01CA049605-27,5898,Biostatistics and Data Management,"LAVORI, PHILIP",STANFORD UNIVERSITY,CA,"$186,995"
Lymphoma,2016,NCI,4P01CA049605-27,5899,Molecular Diagnostics,"ZEHNDER, JAMES",STANFORD UNIVERSITY,CA,"$239,457"
Lymphoma,2016,NCI,4P01CA049605-27,5900,Cell Processing and Sample Distribution Laboratory,"LOWSKY, ROBERT",STANFORD UNIVERSITY,CA,"$377,265"
Lymphoma,2016,NCI,4R01CA117794-11,,Inhibitors of the Epstein-Barr Virus Entry Machinery,"JARDETZKY, THEODORE",STANFORD UNIVERSITY,CA,"$331,208"
Lymphoma,2016,NCI,4R01CA177734-04,,Genetic Biomarkers for Risk Assessment of Peripheral T-Cell Lymphomas,"FELDMAN, ANDREW",MAYO CLINIC ROCHESTER,MN,"$329,925"
Lymphoma,2016,NCI,2P30CA124435-09,7150,Lymphoma & Leukemia Research Program (Project-007),"LEVY, RONALD",STANFORD UNIVERSITY,CA,"$36,782"
Lymphoma,2016,NCI,2P30CA086862-16,7673,Program 4: Cancer Epidemiology and Population Science,"LYNCH, CHARLES",UNIVERSITY OF IOWA,IA,"$32,573"
Lymphoma,2016,NCI,2P01CA019014-37,7901,Project 2 - Membrane trafficking in EBV malignancies:  Implication of deubiquitinase UCH-L1,"PAGANO, JOSEPH",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$308,775"
Lymphoma,2016,NCI,2P01CA019014-37,7902,Project 3 - Modulation of host cell biology by KSHV,"DAMANIA, BLOSSOM",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$308,968"
Lymphoma,2016,NCI,2P01CA019014-37,7903,Project 4 - Study of KSHV Carcinogenesis,"DITTMER, DIRK",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$303,998"
Lymphoma,2016,NCI,1R01CA203721-01,,Transforming the diagnosis and care of patients with CTCL using TCR sequencing,"CLARK, RACHAEL",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$742,632"
Lymphoma,2016,NCI,1R01CA204621-01,,Modulation of Host Cell Exosome Content and Function by EBV LMP1,"MECKES, DAVID",FLORIDA STATE UNIVERSITY,FL,"$341,849"
Lymphoma,2016,NCI,4R01CA164679-05,,HVEM-BTLA Pathway in Lymphoma,"WARE, CARL",SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE,CA,"$404,625"
Lymphoma,2016,NIAAA,1R01AA024770-01,,"A pooling project on alcohol use and risk of cancers with inconsistent prior evidence, with an emphasis in non-smokers.","FERRARI, PIETRO",INTERNATIONAL AGENCY FOR RES ON CANCER,FR,"$513,904"
Lymphoma,2016,NIAID,1R01AI123420-01,,Targeting Epstein-Barr Virus super-enhancers,"KIEFF, ELLIOTT",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$443,750"
Lymphoma,2016,NIAID,1R01AI121300-01A1,,Non-coding RNAs in Gammaherpesvirus Infection and Disease,"VAN DYK, LINDA",UNIVERSITY OF COLORADO DENVER,CO,"$385,420"
Lymphoma,2016,NCI,5R03CA186223-02,,Do cardiovascular risk factors modify the cardiotoxicity of lymphoma treatments?,"SALZ, TALYA",SLOAN-KETTERING INST CAN RESEARCH,NY,"$87,950"
Lymphoma,2016,NCI,5R21CA196348-02,,HHV-8 vIRF interactions in the context of infection,"NICHOLAS, JOHN",JOHNS HOPKINS UNIVERSITY,MD,"$211,410"
Lymphoma,2016,NIDDK,5K08DK100739-02,,The Intraepithelial T cell Response in Celiac Disease,"HAN, ARNOLD",STANFORD UNIVERSITY,CA,"$143,963"
Lymphoma,2016,NCI,5R01CA095318-12,,Role of B cells in murine gammaherpesvirus 68,"SPECK, SAMUEL",EMORY UNIVERSITY,GA,"$368,305"
Lymphoma,2016,NCI,4P30CA046592-28,6464,Hematologic Malignancies/BMT,"WICHA, MAX",UNIVERSITY OF MICHIGAN,MI,"$335,881"
Lymphoma,2016,NCI,5R21CA185875-02,,Novel AHCT Regimen for Advanced Hodgkin Lymphoma using Y-90 anti-CD25 with BEAM,"SMITH, EILEEN",BECKMAN RESEARCH INSTITUTE/CITY OF HOPE,CA,"$174,122"
Lymphoma,2016,NCI,4K08CA172215-04,,The role of GATA-3 in T-cell lymphomas,"WILCOX, RYAN",UNIVERSITY OF MICHIGAN,MI,"$178,618"
Lymphoma,2016,NCI,5R01CA189806-03,,Impact of malaria on shaping immunity to EBV in the etiology of Burkitt lymphoma,"MOORMANN, ANN",UNIV OF MASSACHUSETTS MED SCH WORCESTER,MA,"$576,703"
Lymphoma,2016,NCI,5R21CA184469-02,,Generation of NKT cells from adult stem cells for adoptive immunotherapy,"WEBB, TONYA",UNIVERSITY OF MARYLAND BALTIMORE,MD,"$166,931"
Lymphoma,2016,NCI,4R01CA180150-04,,(PQD1) Treatment-emergent resistance to NEDD8-activating enzyme inhibition,"PETROSKI, MATTHEW",SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE,CA,"$558,328"
Lymphoma,2016,NCI,4R01CA168477-05,,Immune Modulation by Gammaherpesviruses,"COSCOY, LAURENT",UNIVERSITY OF CALIFORNIA BERKELEY,CA,"$234,200"
Lymphoma,2016,NCI,4R01CA129974-10,,Probing mitochondria and personalizing leukemia therapy with BH3 profiling,"LETAI, ANTHONY",DANA-FARBER CANCER INST,MA,"$315,153"
Lymphoma,2016,NCI,4P01CA119070-10,7558,Notch 1 Regulation of T-ALL Genomes,"ASTER, JON",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$292,907"
Lymphoma,2016,NCI,5F30CA186458-03,,High-resolution analysis of chromatin regulation by the Max network,"KASINATHAN, SIVAKANTHAN",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$48,576"
Lymphoma,2016,NCI,5F32CA183381-03,,c-MYC dependent regulation of de novo lipogenesis in B-cell lymphomagenesis,"SCOTT, KRISTEN",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$59,970"
Lymphoma,2016,NCI,4R01CA158402-05,,Molecular mechanisms of B cell malignant transformation,"XIE, PING","RUTGERS, THE STATE UNIV OF N.J.",NJ,"$322,456"
Lymphoma,2016,NIAID,1R21AI124129-01,,Generation of a mouse expressing a photoactivatable Cre recombinase,"SCHWAB, SUSAN",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$254,250"
Lymphoma,2016,NIAID,1R21AI124172-01,,Rab7 and NF-kappaB in B cell activation and dysregulation,"XU, ZHENMING",UNIVERSITY OF TEXAS HLTH SCIENCE CENTER,TX,"$225,338"
Lymphoma,2016,NCI,1R21CA206104-01,,Mechanisms of c-CBL Regulation in Cutaneous T-Cell Lymphoma (CTCL),"WOOD, GARY",UNIVERSITY OF WISCONSIN-MADISON,WI,"$199,665"
Lymphoma,2016,NIAID,5R21AI119480-02,,Structure and function of EBV protein complexes that trigger epithelial cell entry,"JARDETZKY, THEODORE",STANFORD UNIVERSITY,CA,"$195,417"
Lymphoma,2016,NCI,5R01CA194547-02,,The identification and validation of mechanisms and biomarkers for relapse in diffuse large B-cell lymphoma,"ELEMENTO, OLIVIER",WEILL MEDICAL COLL OF CORNELL UNIV,NY,"$530,098"
Lymphoma,2016,RMAP,5K01ES025431-04,,The role of epigenetic heterogeneity in CLL evolution,"LANDAU, DAN",WEILL MEDICAL COLL OF CORNELL UNIV,NY,"$187,920"
Lymphoma,2016,NCI,5K23CA184279-03,,Molecular determinants of prognosis in limited-stage follicular lymphoma,"LOUISSAINT, ABNER",MASSACHUSETTS GENERAL HOSPITAL,MA,"$140,263"
Lymphoma,2016,NCI,5R01CA197870-02,,Improving BTK Directed Therapy for CLL,"WOYACH, JENNIFER",OHIO STATE UNIVERSITY,OH,"$352,275"
Lymphoma,2016,NCI,5R21CA199544-02,,NKT cells with chimeric antigen receptors,"WEBB, TONYA",UNIVERSITY OF MARYLAND BALTIMORE,MD,"$200,318"
Lymphoma,2016,NCI,4R01CA130995-09,,"Replication Licensing in Genome Stability, Cancer and Aging","PRUITT, STEVEN",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$324,743"
Lymphoma,2016,NIAID,1R01AI124186-01,,RNA-directed targeting of AID in immunity and genomic integrity,"CHAUDHURI, JAYANTA",SLOAN-KETTERING INST CAN RESEARCH,NY,"$428,500"
Lymphoma,2016,NIAMS,4R01AR063962-04,,CTCL immunobiology: lessons from alemtuzumab,"CLARK, RACHAEL",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$366,977"
Lymphoma,2016,NCI,5U01CA195568-02,,The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study,"CERHAN, JAMES",MAYO CLINIC ROCHESTER,MN,"$2,251,244"
Lymphoma,2016,FIC,4K01TW009488-05,,Developing a clinical cohort of histopathologically characterized lymphoma,"GOPAL, SATISH",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$140,175"
Lymphoma,2016,NCI,1R01CA196671-01A1,,Mechanisms of Human Lymphoid Chromosomal Translocation,"LIEBER, MICHAEL",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$377,438"
Lymphoma,2016,NCI,5F30CA189740-03,,Alternative End-Joining in DNA Repair and Chromosomal Translocations,"KUMAR, VIPUL",HARVARD MEDICAL SCHOOL,MA,"$31,559"
Lymphoma,2016,NIAID,5R21AI118509-03,,TRIM protein-mediated innate immune control of KSHV infection,"GACK, MICHAELA",UNIVERSITY OF CHICAGO,IL,"$237,000"
Lymphoma,2016,NCI,5R01CA197945-02,,The role of RHOA G17V mutation in peripheral t-cell lymphomas,"PALOMERO, TERESA",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$366,000"
Lymphoma,2016,NCI,1R01CA206019-01,,"Host factors, tumor microenvironment and survival in a multiethnic study of Hodgkin lymphoma patients","COZEN, WENDY",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$735,600"
Lymphoma,2016,NCI,1R21CA195431-01A1,,Role of Follicular Dendritic Cells in B lymphoma,"RICKERT, ROBERT",SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE,CA,"$254,475"
Lymphoma,2016,NCI,5R01CA163910-05,,TARGETING ANTIGEN-INDUCED ER STRESS RESPONSE IN B-CELL CHRONIC LYMPHOCYTIC LEUKEM,"HU, CHIH-CHI",WISTAR INSTITUTE,PA,"$380,146"
Lymphoma,2016,NCI,5K08CA197367-02,,The role of Galpha13 signaling in development and dissemination of lymphoma,"MUPPIDI, JAGAN","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$175,495"
Lymphoma,2016,NCI,5R03CA188619-02,,THE ROLE OF MALT1 IN MELANOMA GROWTH AND METASTASIS,"ZHANG, YUNYAN JENNIFER",DUKE UNIVERSITY,NC,"$79,500"
Lymphoma,2016,NCI,5R21CA198072-02,,Passenger mutations due to activation-induced deaminase as biomarkers in lymphoma,"BURACK, WALTER",UNIVERSITY OF ROCHESTER,NY,"$171,852"
Lymphoma,2016,NCI,5P30CA013696-42,6105,Lymphoid Development and Malignancy Program,"EMERSON, STEPHEN",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$35,133"
Lymphoma,2016,NCI,5P30CA013696-42,6127,Recruitment,"EMERSON, STEPHEN",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$95,447"
Lymphoma,2016,NIGMS,4SC3GM103713-04,,Characterization of novel compounds with anti-lymphoma activity,"AGUILERA, RENATO",UNIVERSITY OF TEXAS EL PASO,TX,"$113,250"
Lymphoma,2016,NCI,5R21CA198561-02,,SYNERGIZING PRO-APOPTOTIC AND CAR-T CELL IMMUNOTHERAPY FOR MANTLE CELL LYMPHOMA,"KATZ, SAMUEL",YALE UNIVERSITY,CT,"$181,069"
Lymphoma,2016,NCI,2R01CA151898-06A1,,CRLF2 signaling in B-cell acute lymphoblastic leukemia,"WEINSTOCK, DAVID",DANA-FARBER CANCER INST,MA,"$392,969"
Lymphoma,2016,NCI,2R01CA155010-06,,Personal tumor neoantigens for immunity against chronic lymphocytic leukemia,"WU, CATHERINE",DANA-FARBER CANCER INST,MA,"$675,300"
Lymphoma,2016,NCI,4P01CA018029-41,5850,Nonmyeloablative Hematopoietic Cell Allotransplants,"STORB, RAINER",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$334,135"
Lymphoma,2016,NCI,5F32CA180499-03,,Targeting Chronic Lymphocytic Leukemia with DNA Nanoparticles,"RUFF, LAURA",UNIVERSITY OF CALIFORNIA SAN DIEGO,CA,"$59,970"
Lymphoma,2016,NCI,4K24CA125440-10,,Clinical and Molecular Studies of Malignant Brain Tumors,"BATCHELOR, TRACY",MASSACHUSETTS GENERAL HOSPITAL,MA,"$185,972"
Lymphoma,2016,NCI,5R01CA197801-02,,Identification of Loci Modifying Atm Lymphomagenesis,"WEIL, MICHAEL",COLORADO STATE UNIVERSITY,CO,"$341,468"
Lymphoma,2016,NCI,5R01CA093237-15,,Nuclear Accumulation of Cyclin D1 and Oncogenesis,"DIEHL, JOHN",MEDICAL UNIVERSITY OF SOUTH CAROLINA,SC,"$278,127"
Lymphoma,2016,NCI,5K08CA191019-03,,The Role of ZEB1 Mutations in Cutaneous T Cell Lymphoma,"CHOI, JAEHYUK",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$152,604"
Lymphoma,2016,NCI,5R01CA190628-02,,Overcoming Resistance to Anti-EGFR Therapy by Drug Repurposing,"FANG, BINGLIANG",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$514,090"
Lymphoma,2016,NIAID,1R21AI115313-01A1,,Targeting B Cell MicroRNA in Post-Transplant EBV-Associated B Cell Lymphoma,"MARTINEZ, OLIVIA",STANFORD UNIVERSITY,CA,"$237,417"
Lymphoma,2016,NIBIB,1R21EB020237-01A1,,Switchable Molecular Nanoprobes for Fast and Specific Intraoperative Diagnosis of Brain Tumors,"YAN, HAO",ARIZONA STATE UNIVERSITY-TEMPE CAMPUS,AZ,"$232,513"
Lymphoma,2016,NCI,5R01CA196703-02,,Mechanisms of resistance to ALK inhibitors in ALK-rearranged lymphoma,"CHIARLE, ROBERTO",CHILDREN'S HOSPITAL CORPORATION,MA,"$404,888"
Lymphoma,2016,NIGMS,5R01GM106067-03,,DNA-carbon Assemblies for Multispectral Imaging,"KOOL, ERIC",STANFORD UNIVERSITY,CA,"$302,405"
Lymphoma,2016,NCI,4R01CA161151-04,,Lig4R278H contribution to HSC and IgH class switching defects and malignancies,"YAN, CATHERINE",BETH ISRAEL DEACONESS MEDICAL CENTER,MA,"$377,086"
Lymphoma,2016,NCI,5F31CA183504-03,,Non-catalytic functions of DNA-PK in DNA repair and tumorigenesis,"CROWE, JENNIFER",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$43,576"
Lymphoma,2016,NCI,5F31CA196153-02,,The Use of Novel Peptide Probes to Study Proteasome Regulation by Src Family Kinases in Diffuse Large B-cell Lymphoma,"CANN, MARISSA",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$31,321"
Lymphoma,2016,NCI,4R01CA103646-10,,Modeling KSHV latency in vivo,"CESARMAN, ETHEL",WEILL MEDICAL COLL OF CORNELL UNIV,NY,"$328,499"
Lymphoma,2016,NCI,4P01CA180779-04,8771,Roles of the K3 and K5 in KSHV Persistence and Pathogenesis,"JUNG, JAE",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$363,961"
Lymphoma,2016,NCI,4P01CA180779-04,8772,Roles of Nucleotide Metabolic Control in KSHV Persistence,"JUNG, JAE",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$363,960"
Lymphoma,2016,NCI,4P01CA180779-04,8776,Core Director: Hye-Ra-Lee,"JUNG, JAE",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$106,572"
Lymphoma,2016,NCI,5R01CA136895-08,,Understanding the context-dependent roles of mutations in lymphoma.,"DAVE, SANDEEP",DUKE UNIVERSITY,NC,"$286,200"
Lymphoma,2016,NCI,4P50CA097274-15,7186,In Situ Immunization Using Nanoparticles,"WEINER, GEORGE",UNIVERSITY OF IOWA,IA,"$182,388"
Lymphoma,2016,NCI,4P50CA097274-15,7184,The Role of Monocytes in non-Hodgkin Lymphoma,"ANSELL, STEPHEN",UNIVERSITY OF IOWA,IA,"$279,404"
Lymphoma,2016,NCI,4P50CA097274-15,7191,Genetic Epidemiology and Function of Germline and Somatic Variants in DLBCL,"CERHAN, JAMES",UNIVERSITY OF IOWA,IA,"$272,388"
Lymphoma,2016,NCI,4P50CA097274-15,7189,Targeting JAK2 Kinase in Lymphoma,"GUPTA, MAMTA",UNIVERSITY OF IOWA,IA,"$274,574"
Lymphoma,2016,NCI,4P50CA097274-15,7192,Administration,"WEINER, GEORGE",UNIVERSITY OF IOWA,IA,"$133,118"
Lymphoma,2016,NCI,4P50CA097274-15,7194,Biospecimens,"DOGAN, AHMET",UNIVERSITY OF IOWA,IA,"$278,708"
Lymphoma,2016,NCI,4P50CA097274-15,7195,Biostatistics and Bioinformatics,"SMITH, BRIAN",UNIVERSITY OF IOWA,IA,"$194,697"
Lymphoma,2016,NCI,4P50CA097274-15,7197,DEVELOPMENTAL RESEARCH PROGRAM,"LENTZ, STEVEN",UNIVERSITY OF IOWA,IA,"$150,780"
Lymphoma,2016,NCI,4P50CA097274-15,7196,Clinical Research,"HABERMANN, THOMAS",UNIVERSITY OF IOWA,IA,"$301,818"
Lymphoma,2016,NCI,4P50CA097274-15,7198,CAREER DEVELOPMENT PROGRAM,"HOHL, RAYMOND",UNIVERSITY OF IOWA,IA,"$93,500"
Lymphoma,2016,NCI,4R01CA096500-14,,Role of KSHV viral proteins in signaling and pathogenesis,"DAMANIA, BLOSSOM",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$281,108"
Lymphoma,2016,NCI,4R01CA163587-05,,IMAGING T CELLS BY POSITRON EMISSION TOMOGRAPHY,"NAJJAR, AMER",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$582,458"
Lymphoma,2016,NIDCR,1R01DE025985-01,,KSHV Replication in Oral Epithelial Cells,"IZUMIYA, YOSHIHIRO",UNIVERSITY OF CALIFORNIA AT DAVIS,CA,"$392,083"
Lymphoma,2016,NIGMS,5R01GM095606-06,,Drug-Free Macromolecular Therapeutics,"KOPECEK, JINDRICH",UNIVERSITY OF UTAH,UT,"$298,000"
Lymphoma,2016,NIDCR,1R01DE025994-01,,Targeting Apoptosis and Immune Control of Epstein-Barr Virus Infected Tonsillar B Cells,"LUFTIG, MICAH",DUKE UNIVERSITY,NC,"$426,328"
Lymphoma,2016,NIDCR,1R01DE026003-01,,Targeting an immune kinase to purge KSHV latent infection,"FENG, PINGHUI",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$676,564"
Lymphoma,2016,NCI,5R01CA076287-17,,Pretargeted Radioimmunotherapy of CD20+ Lymphomas,"PRESS, OLIVER",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$383,270"
Lymphoma,2016,NCI,5R01CA188794-03,,Cell cycle reprogramming for therapeutic targeting of BTK in lymphoma,"CHEN-KIANG, SELINA",WEILL MEDICAL COLL OF CORNELL UNIV,NY,"$351,713"
Lymphoma,2016,NIGMS,5R01GM112192-03,,Enhancer Driven Gene Regulation During Lymphocyte Development,"SKOK, JANE",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$525,166"
Lymphoma,2016,NCI,4P50CA126752-10,0001,T CELL THERAPY TARGETING MULTIPLE TUMOR ANTIGENS IN HODGKIN LYMPHOMA,"LEEN, ANN",BAYLOR COLLEGE OF MEDICINE,TX,"$233,474"
Lymphoma,2016,NCI,4P50CA126752-10,0002,CHIMERIC T CELL ANTIGENS TARGETING IG KAPPA LIGHT CHAIN IN B CELL LYMPHOMA,"DOTTI, GIANPIETRO",BAYLOR COLLEGE OF MEDICINE,TX,"$220,316"
Lymphoma,2016,NCI,4P50CA126752-10,0003,BUILDING ON SUCCESSFUL T CELL THERAPY FOR EBV LYMPHOMA,"ROONEY, CLIONA",BAYLOR COLLEGE OF MEDICINE,TX,"$214,761"
Lymphoma,2016,NCI,4P50CA126752-10,0004,TARGETING CHEMORESISTANT TUMOR-INITIATING CELLS IN CLL,"FOSTER, AARON",BAYLOR COLLEGE OF MEDICINE,TX,"$218,564"
Lymphoma,2016,NCI,4P50CA126752-10,0006,ADMINISTRATIVE CORE,"HESLOP, HELEN",BAYLOR COLLEGE OF MEDICINE,TX,"$140,645"
Lymphoma,2016,NCI,4P50CA126752-10,9001,Clinical Research Core,"HESLOP, HELEN",BAYLOR COLLEGE OF MEDICINE,TX,"$143,969"
Lymphoma,2016,NCI,4P50CA126752-10,9002,Biostatistics,"LIU, HAO",BAYLOR COLLEGE OF MEDICINE,TX,"$135,982"
Lymphoma,2016,NCI,4P50CA126752-10,9003,Cell and Vector Production,"GEE, ADRIAN",BAYLOR COLLEGE OF MEDICINE,TX,"$262,251"
Lymphoma,2016,NCI,4P50CA126752-10,9004,BIOSPECIMEN AND PATHOLOGY CORE,"SHEEHAN, ANDREA",BAYLOR COLLEGE OF MEDICINE,TX,"$280,413"
Lymphoma,2016,NCI,4P50CA126752-10,7045,DEVELOPMENTAL RESEARCH PROGRAM,"BRENNER, MALCOLM",BAYLOR COLLEGE OF MEDICINE,TX,"$155,811"
Lymphoma,2016,NCI,4P50CA126752-10,7046,CAREER DEVELOPMENT PROGRAM,"HESLOP, HELEN",BAYLOR COLLEGE OF MEDICINE,TX,"$155,811"
Lymphoma,2016,NCI,5R01CA187109-03,,Targeting EZH2 in Germinal Center Derived B-Cell Lymphoma,"MELNICK, ARI",WEILL MEDICAL COLL OF CORNELL UNIV,NY,"$379,082"
Lymphoma,2016,NCI,4U01CA166905-04,,Identifying non-coding RNAs for early detection and prevention of lung cancer,"CROCE, CARLO",OHIO STATE UNIVERSITY,OH,"$897,104"
Lymphoma,2016,NCI,5R01CA187799-02,,Role of FOXP1 and WNT signaling in B-cell Lymphoma,"MAJOR, MICHAEL",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$307,500"
Lymphoma,2016,NCI,5R42CA183708-05,,An Early-Phase Clinical Trial Evaluating ABC294640 in Patients with Refractory/Re,"PARSONS, CHRISTOPHER",APOGEE BIOTECHNOLOGY CORPORATION,PA,"$133,116"
Lymphoma,2016,NCI,1F31CA206236-01,,Computational Analysis of Subclonal Evolution in Chronic Lymphocytic Leukemia,"FAN, JEAN",HARVARD MEDICAL SCHOOL,MA,"$34,102"
Lymphoma,2016,NCI,5P01CA100730-13,5163,Core C: Animal Models,"NIEWIESK, STEFAN",OHIO STATE UNIVERSITY,OH,"$305,738"
Lymphoma,2016,NCI,5P01CA100730-13,5166,Project 3: Effect of HTLV-1 Viral Oncogenes on the Bone Microenvironment in ATL,"WEILBAECHER, KATHERINE",OHIO STATE UNIVERSITY,OH,"$313,489"
Lymphoma,2016,NCI,5P01CA100730-13,5167,Project 4: Tumorigenic Effects of Tax,"RATNER, LEE",OHIO STATE UNIVERSITY,OH,"$437,669"
Lymphoma,2016,NCI,4K23CA178183-04,,Targeted Therapies and Mechanisms of Resistance in Chronic Lymphocytic Leukemia,"WOYACH, JENNIFER",OHIO STATE UNIVERSITY,OH,"$173,232"
Lymphoma,2016,NCI,4P01CA165997-04,8409,Micro-RNA-dependent regulation of the UPR,"DIEHL, JOHN",UNIVERSITY OF PENNSYLVANIA,PA,"$310,156"
Lymphoma,2016,NCI,4P01CA165997-04,8411,Role of the UPR in myc-induced tumorigenesis,"KOUMENIS, CONSTANTINOS",UNIVERSITY OF PENNSYLVANIA,PA,"$262,116"
Lymphoma,2016,NCI,4P01CA165997-04,8412,"UPR, interferon signaling and tumorigenesis","FUCHS, SERGE",UNIVERSITY OF PENNSYLVANIA,PA,"$282,566"
Lymphoma,2016,FIC,5U54CA190146-03,6249,Project 2,"CASPER, COREY",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$7,418"
Lymphoma,2016,NCI,5U54CA190146-03,6249,Project 2,"CASPER, COREY",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$102,858"
Lymphoma,2016,NHLBI,5R01HL114564-04,,Enhancement of stem cell transplants using CAR.CD30-redirected T lymphocytes,"SAVOLDO, BARBARA",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$447,090"
Lymphoma,2016,NCI,1F30CA206343-01,,The cyclic AMP/phosphodiesterase4 axis regulates proximal B cell receptor signaling and offers a new therapeutic strategy for B cell lymphomas,"COONEY, JEFFREY",UNIVERSITY OF TEXAS HLTH SCIENCE CENTER,TX,"$31,776"
Lymphoma,2016,NCI,5R03CA199515-02,,Occupational Pesticide Use and Risk of Lymphoid Cancers,"DE ROOS, ANNECLAIRE",DREXEL UNIVERSITY,PA,"$78,250"
Lymphoma,2016,NIAID,5R01AI045073-18,,Chemokines and Lymphoid Tissue Organization and Function,"CYSTER, JASON","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$356,625"
Lymphoma,2016,NCI,4R01CA182736-04,,MALT1 inhibitors for the treatment of chemo-resistant ABC-DLBCL,"GRAY, NATHANAEL",DANA-FARBER CANCER INST,MA,"$700,976"
Lymphoma,2016,FIC,5U54CA190152-03,7397,Project 2,"GOPAL, SATISH",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$14,324"
Lymphoma,2016,NCI,5U54CA190152-03,7397,Project 2,"GOPAL, SATISH",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$200,501"
Lymphoma,2016,FIC,5U54CA190152-03,7398,Project 3,"GOPAL, SATISH",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$11,348"
Lymphoma,2016,NCI,5U54CA190152-03,7398,Project 3,"GOPAL, SATISH",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$158,852"
Lymphoma,2016,NCI,1R21CA206309-01,,"(PQ2) HIV INFECTION, APOBEC UPREGULATION, AND CANCER MUTAGENESIS","HARRIS, REUBEN",UNIVERSITY OF MINNESOTA,MN,"$219,289"
Lymphoma,2016,NCI,5R00CA157954-05,,Convergence of CREB and MYC Pathways in Oncogenesis.,"AMELIO, ANTONIO",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$249,000"
Lymphoma,2016,NCI,1R01CA206476-01,,(PQ3) Identifying Novel Pharmacologic Risk factors for Common Non-AIDS Defining Cancers in Individuals with Well-controlled HIV Infection,"CHIAO, ELIZABETH",BAYLOR COLLEGE OF MEDICINE,TX,"$772,521"
Lymphoma,2016,NCI,5R01CA139083-08,,Recognition and Targeting of CNS Lymphoma by Tumor-Associated Macrophages,"RUBENSTEIN, JAMES","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$370,554"
Lymphoma,2016,NCI,4P30CA082103-18,6392,Hematopoietic Malignancies,"MCCORMICK, FRANK","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,$163
Lymphoma,2016,NCI,5K99CA190803-02,,The role of PRDM1 in epigenetic regulation and tumor suppression,"CARLSON, SCOTT",STANFORD UNIVERSITY,CA,"$112,614"
Lymphoma,2016,NCI,5R33CA191159-02,,Using Adductomics to Characterize Exposures to Carcinogens,"RAPPAPORT, STEPHEN",UNIVERSITY OF CALIFORNIA BERKELEY,CA,"$379,613"
Lymphoma,2016,NCI,5R01CA136551-08,,Targeted therapy of B cell malignances with CAR-T cells of defined composition,"RIDDELL, STANLEY",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$560,424"
Lymphoma,2016,NCI,5R01CA187492-03,,MALT1 Targeted Therapy for B-Cell Lymphoma,"MELNICK, ARI",WEILL MEDICAL COLL OF CORNELL UNIV,NY,"$351,713"
Lymphoma,2016,NCI,5R01CA190696-03,,A New Treatment Paradigm for ALK-Driven Cancers Exploiting Oncogene Overdose,"SCHATZ, JONATHAN",UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,FL,"$299,009"
Lymphoma,2016,NCI,5R21CA191380-02,,Role of lncRNAs in Clinical Heterogeneity of Early Stage IGHV Unmutated CLL,"JELINEK, DIANE",MAYO CLINIC ROCHESTER,MN,"$172,913"
Lymphoma,2016,NCI,4P01CA174439-04,8216,Role of LANA-RBP-jk During Early KSHV Infection,"ROBERTSON, ERLE",UNIVERSITY OF PENNSYLVANIA,PA,"$379,491"
Lymphoma,2016,NCI,4P01CA174439-04,8218,Chromatin Regulation of KSHV Primary Infection,"LIEBERMAN, PAUL",WISTAR INSTITUTE,PA,"$399,880"
Lymphoma,2016,NCI,5R35CA197734-02,,Targeted Therapy for Leukemia,"BYRD, JOHN",OHIO STATE UNIVERSITY,OH,"$914,298"
Lymphoma,2016,NIDCR,4DP5OD012160-06,,Detection of Chromosomal Translocations by Single Molecule RNA Imaging,"BATISH, MONA",RBHS-NEW JERSEY MEDICAL SCHOOL,NJ,$1
Lymphoma,2016,RMAP,4DP5OD012160-06,,Detection of Chromosomal Translocations by Single Molecule RNA Imaging,"BATISH, MONA",RBHS-NEW JERSEY MEDICAL SCHOOL,NJ,"$397,499"
Lymphoma,2016,NCI,5P01CA078902-18,5395,Project 3: Stem Cell Allografts for Lymphoid Malignancies,"MALONEY, DAVID",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$257,616"
Lymphoma,2016,NCI,5P01CA078902-18,7384,Program Integration and management,"STORB, RAINER",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$18,647"
Lymphoma,2016,NIDCR,5R01DE024971-02,,Platform technology for detection of cancer-associated viruses in HIV patients,"DEMIRCI, UTKAN",STANFORD UNIVERSITY,CA,"$422,708"
Lymphoma,2016,NCI,2R01CA076445-15,,Studies of HHV-8 vIL-6 Function,"NICHOLAS, JOHN",JOHNS HOPKINS UNIVERSITY,MD,"$384,750"
Lymphoma,2016,NCI,7R01CA179062-02,,Role of Specific Histone Deacetylases in Lymphoma Immunobiology and Therapy,"SOTOMAYOR, EDUARDO",GEORGE WASHINGTON UNIVERSITY,DC,"$362,569"
Lymphoma,2016,NCI,2R42CA183197-02A1,,Developing Therapeutics That Target RAD51 To Treat Leukemia and Lymphoma,"MILLS, KEVIN","CYTEIR THERAPEUTICS, INC.",MA,"$1,038,983"
Lymphoma,2016,NCI,5R21CA199553-02,,Optimization and Efficacy of Covalent Ire-1 RNase Inhibitors in CLL,"DEL VALLE, JUAN",UNIVERSITY OF SOUTH FLORIDA,FL,"$207,616"
Lymphoma,2016,NCI,4P01CA081534-16,6644,Molecular Genetics,"CROCE, CARLO",OHIO STATE UNIVERSITY,OH,"$434,909"
Lymphoma,2016,NCI,4P01CA081534-16,6645,Molecular Inhibition of Apoptosis Inhibitors,"REED, JOHN",SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE,CA,"$369,989"
Lymphoma,2016,NCI,4P01CA081534-16,6646,Immune Therapy,"KIPPS, THOMAS",UNIVERSITY OF CALIFORNIA SAN DIEGO,CA,"$196,902"
Lymphoma,2016,NCI,4P01CA081534-16,6647,Immune Tolerance and Stem Cell Transplantation,"GRIBBEN, JOHN",UNIVERSITY OF CALIFORNIA SAN DIEGO,CA,"$197,537"
Lymphoma,2016,NCI,4P01CA081534-16,6648,Mechanism-Based Pharmacologic Intervention,"PLUNKETT, WILLIAM",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$118,119"
Lymphoma,2016,NCI,4P01CA081534-16,6649,Pharmacologic Inhibitors of Cellular Kinases and Signal Transduction,"GREVER, MICHAEL",OHIO STATE UNIVERSITY,OH,"$183,413"
Lymphoma,2016,NCI,4P01CA081534-16,6650,Administrative and Informatics,"KIPPS, THOMAS",UNIVERSITY OF CALIFORNIA SAN DIEGO,CA,"$497,601"
Lymphoma,2016,NCI,4P01CA081534-16,6651,Biostatistics,"NEUBERG, DONNA",DANA-FARBER CANCER INST,MA,"$142,753"
Lymphoma,2016,NCI,4P01CA081534-16,6652,Tissue Core,"RASSENTI, LAURA",UNIVERSITY OF CALIFORNIA SAN DIEGO,CA,"$443,591"
Lymphoma,2016,NCI,4P01CA081534-16,6653,Clinical Program,"WIERDA, WILLIAM",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$519,497"
Lymphoma,2016,NCI,5R35CA197706-02,,Cancer Gene Discovery to Identify Targetable Targets,"CROCE, CARLO",OHIO STATE UNIVERSITY,OH,"$924,000"
Lymphoma,2016,NCI,4P01CA015396-41,5878,Targeting Cancer Stem Cells,"JONES, RICHARD",JOHNS HOPKINS UNIVERSITY,MD,"$343,404"
Lymphoma,2016,NCI,5R01CA190860-02,,Pharmacological Blockage of XBP-1s Expression in Cancer,"DEL VALLE, JUAN",UNIVERSITY OF SOUTH FLORIDA,FL,"$456,149"
Lymphoma,2016,NCI,5K22CA193674-02,,Lymphoma monocyte crosstalk: mechanisms of chemo-immunotherapy resistance,"LIN, YI",MAYO CLINIC ROCHESTER,MN,"$192,780"
Lymphoma,2016,NCI,5R01CA185372-03,,(PQD5) A novel genetic strategy to predict efficacy of anti-CD20 antibodies,"RICHARDS, KRISTY",CORNELL UNIVERSITY,NY,"$321,937"
Lymphoma,2016,NCI,4P01CA095426-15,5850,Innate Immune Therapy for B-Cell Malignancies,"BYRD, JOHN",OHIO STATE UNIVERSITY,OH,"$381,967"
Lymphoma,2016,NCI,4P01CA095426-15,5857,MOUSE MODELING AND ANIMAL DEVELOPMENT,"MUTHUSAMY, NATARAJAN",OHIO STATE UNIVERSITY,OH,"$247,366"
Lymphoma,2016,NCI,5R44CA195812-02,,Combination Immunotherapy of a Novel Superagonist IL-15 Complex and Anti-CD20 Antibody for Indolent Non-Hodgkin Lymphoma,"WONG, HING",ALTOR BIOSCIENCE CORPORATION,FL,"$966,343"
Lymphoma,2016,NCI,5K24CA201524-02,,Development of a comprehensive research program in mantle cell lymphoma in the ibrutinib era,"BLUM, KRISTIE",OHIO STATE UNIVERSITY,OH,"$178,543"
Lymphoma,2016,NCI,5P01CA016038-42,7371,"Project 1, Miller: Novel Functions of the Epstein-Barr Viral Lytic Cycle Activator Protein ZEBRA","MILLER, I.",YALE UNIVERSITY,CT,"$197,935"
Lymphoma,2016,NCI,5P01CA016038-42,7373,"Project 3, Steitz: Viral Noncoding RNAs and Cell Transformation","STEITZ, JOAN",YALE UNIVERSITY,CT,"$123,787"
Lymphoma,2016,NCI,1P01CA206978-01,5148,"Discovery of clinically distinct CLL subgroups by integrative mapping of large-scale CLL genetic, expression and clinical data","GETZ, GAD","BROAD INSTITUTE, INC.",MA,"$250,834"
Lymphoma,2016,NCI,1P01CA206978-01,5149,CLL  clonal  evolution  and  the  development  of  therapy-driven  resistance,"WU, CATHERINE",DANA-FARBER CANCER INST,MA,"$250,834"
Lymphoma,2016,NCI,5R01CA184137-02,,Therapeutic resistance in leukemic cells: targeting BCL-2 family and autophagy,"ALMASAN, ALEXANDRU",CLEVELAND CLINIC LERNER COM-CWRU,OH,"$362,569"
Lymphoma,2016,NCI,5R01CA197844-02,,Phosphatase activation as therapeutic strategy for Chronic lymphocyic leukemia,"MUTHUSAMY, NATARAJAN",OHIO STATE UNIVERSITY,OH,"$437,656"
Lymphoma,2016,NCI,5UM1CA121947-10,,AIDS Malignancy Consortium (AMC),"MITSUYASU, RONALD",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$21,619,997"
Lymphoma,2016,NCI,5R01CA197120-02,,Predicting clinical outcome in individuals with small CLL B cell clones,"SHANAFELT, TAIT",MAYO CLINIC ROCHESTER,MN,"$611,624"
Lymphoma,2016,NCI,5P01CA190193-02,8720,Project 1: Direct & Repeated pO2 Measurements for Cancer using EPR with Carbon Pa,"KUPPUSAMY, PERIANNAN",DARTMOUTH COLLEGE,NH,"$476,425"
Lymphoma,2016,NCI,5P30CA091842-15,6313,Hematopoietic Development and Malignancy (Project-002),"EBERLEIN, TIMOTHY",WASHINGTON UNIVERSITY,MO,"$64,408"
Lymphoma,2016,NIAID,1R01AI125397-01,,Uracil DNA Glycosylases in Gammaherpesvirus Pathogenesis and B Cell Development,"MCBRIDE, KEVIN",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$500,503"
Lymphoma,2016,NCI,1R01CA207513-01,,Role of KLHL6 inactivation in mature B-cell malignancies,"BUSINO, LUCA",UNIVERSITY OF PENNSYLVANIA,PA,"$368,288"
Lymphoma,2016,NCI,1R01CA208398-01,,CAR-T cell control through orthogonal antibody-based switches,"YOUNG, TRAVIS",CALIFORNIA INSTITUTE/BIOMEDICAL RESEARCH,CA,"$419,739"
Lymphoma,2016,NCI,1K08CA208013-01,,Oncogenic programs driven by Notch signaling in B-cell lymphoma,"RYAN, RUSSELL",MASSACHUSETTS GENERAL HOSPITAL,MA,"$180,360"
Lymphoma,2016,NCI,1K99CA208017-01,,Targeting BRD4 in Chronic Lymphocytic Leukemia (CLL) Disease Progression to Richter's Transformation (RT),"ELGAMAL, DALIA",OHIO STATE UNIVERSITY,OH,"$103,394"
Lymphoma,2016,NCI,1K24CA208132-01,,Mentored Patient Oriented Research in Lymphoma,"FLOWERS, CHRISTOPHER",EMORY UNIVERSITY,GA,"$164,375"
Lymphoma,2016,NCI,3R01CA194547-01S1,,The identification and validation of mechanisms and biomarkers for relapse in diffuse large B-cell lymphoma (Administrative Supplement),"ELEMENTO, OLIVIER",WEILL MEDICAL COLL OF CORNELL UNIV,NY,"$58,302"
Lymphoma,2016,NCI,1R15CA202265-01A1,,Coordinate Regulation of p53 and c-Myc in HTLV-1 and HPV-induced Carcinogenesis,"HARROD, ROBERT",SOUTHERN METHODIST UNIVERSITY,TX,"$436,500"
Lymphoma,2016,NIGMS,1R15GM120685-01,,Total Synthesis of Anticancer Natural Products Using Oxidative Dearomatization,"YUAN, YU",UNIVERSITY OF CENTRAL FLORIDA,FL,"$436,209"
Lymphoma,2016,NCI,1R01CA200703-01A1,,Genetic Epidemiology of non-Hodgkin Lymphoma,"CERHAN, JAMES",MAYO CLINIC ROCHESTER,MN,"$686,290"
Lymphoma,2016,NCI,1R01CA201309-01A1,,How HTLV-I Tax and HBZ control telomerase activity to induce adult T-cell leukemia,"NICOT, CHRISTOPHE",UNIVERSITY OF KANSAS MEDICAL CENTER,KS,"$336,555"
Lymphoma,2016,NCI,2R01CA114536-11,,TARGETING ROR1 WITH CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS,"RIDDELL, STANLEY",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$458,735"
Lymphoma,2016,NHLBI,1R01HL130539-01A1,,STOP-CA: Statins to prevent Cardiotoxicity from Anthracyclines,"SCHERRER-CROSBIE, MARIELLE",MASSACHUSETTS GENERAL HOSPITAL,MA,"$653,591"
Lymphoma,2016,NCI,2R01CA161026-06,,Targetable Immune Evasion Pathways in Hodgkin Lymphoma,"SHIPP, MARGARET",DANA-FARBER CANCER INST,MA,"$410,899"
Lymphoma,2016,NIAID,1R01AI113130-01A1,,New Therapeutics for Post-Transplant Lymphoproliferative Disorder,"MARTINEZ, OLIVIA",STANFORD UNIVERSITY,CA,"$398,138"
Lymphoma,2016,NCI,2R01CA140337-06,,Host pathways regulating Epstein-Barr virus-mediated B cell growth transformation,"LUFTIG, MICAH",DUKE UNIVERSITY,NC,"$371,732"
Lymphoma,2016,NCI,1R01CA201380-01A1,,Identifying/Targeting Mechanisms of Lymphomagenesis Driven by CREBBP Inactivation,"GREEN, MICHAEL",UNIVERSITY OF NEBRASKA MEDICAL CENTER,NE,"$336,377"
Lymphoma,2016,NCI,1R21CA202104-01A1,,Overcoming Primary Ibrutinib Resistance in Mantle Cell Lymphoma Using Patient-Derived Models and Molecular Profiling,"WANG, MICHAEL",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$208,800"
Lymphoma,2016,NCI,1R01CA202712-01A1,,Risk factors for molecular subtypes of NHL a prospective evaluation,"WANG, SOPHIA",BECKMAN RESEARCH INSTITUTE/CITY OF HOPE,CA,"$752,796"
Lymphoma,2016,NCI,1R21CA209107-01,,Molecular Pathways of Interleukin-13 in Cutaneous T-cell Lymphoma,"FUSCHIOTTI, PATRIZIA",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$211,603"
Lymphoma,2016,NCI,1R21CA202358-01A1,,Targeting Beta-Adrenergic Signaling to Control GVH and GVL Responses,"CAO, XUEFANG",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$245,900"
Lymphoma,2016,NCI,1R21CA209341-01,,Repurposing statins to enhance efficacy of BCL-2 antagonists in blood cancer,"FRUMAN, DAVID",UNIVERSITY OF CALIFORNIA-IRVINE,CA,"$178,474"
Lymphoma,2016,NCI,3R01CA168482-04S1,,HIV-driven B cell activation: role in the genesis of AIDS-related lymphoma,"MARTINEZ-MAZA, OTONIEL",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$93,771"
Lymphoma,2016,NIAID,1R21AI122035-01A1,,Role of Nuclear Lamina in the epigenetic regulation of Epstein-Barr Virus Infection,"TEMPERA, ITALO",TEMPLE UNIV OF THE COMMONWEALTH,PA,"$234,000"
Lymphoma,2016,NCI,4R00CA183914-03,,A Novel Oncogenic Role for Cdc20 Implications in Adult T Cell Leukemia Treatment,"WAN, LIXIN",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$248,999"
Lymphoma,2016,NCI,1R35CA197353-01A1,,Enhancing Cancer Immunotherapy: Targeting the Tumor and Targeting the Host,"LEVY, RONALD",STANFORD UNIVERSITY,CA,"$924,071"
Lymphoma,2016,NCI,3R01CA166450-04S1,,Characterizing tumor suppressive functions of microRNAs in B-cell neoplasia,"RAO, DINESH",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$86,429"
Lymphoma,2016,NCI,1R35CA210105-01,,From pathogenesis to new therapeutic targets in Diffuse Large B cell Lymphoma,"DALLA-FAVERA, RICCARDO",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$406,000"
Lymphoma,2016,NCI,1R01CA203836-01A1,,Monocyte promotion of therapy resistance by immune and non-immune mechanisms,"LIN, YI",MAYO CLINIC ROCHESTER,MN,"$363,713"
Lymphoma,2016,NCI,1F31CA210429-01,,WDR5 as a Critical Co-Factor for MYC,"FOSHAGE, AUDRA",VANDERBILT UNIVERSITY,TN,"$28,248"
Lymphoma,2016,NCI,1F30CA210518-01,,Evaluation of Bruton’s Tyrosine Kinase and p110 delta in Mutant Shp2-Induced JMML,"DENG, LISA",INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS,IN,"$36,738"
Lymphoma,2016,NCI,1F30CA210539-01,,Epigenetic activity of normal and cancer-associated mutant H1 linker histones,"HEALTON, SEAN","ALBERT EINSTEIN COLLEGE OF MEDICINE, INC",NY,"$43,576"
Lymphoma,2016,NCI,1R01CA206462-01A1,,SIRT2 Inhibitors for the Treatment of B-cell Lymphoma,"SIMON, JULIAN",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$573,293"
Lymphoma,2016,NCI,261200800001E-96-0-35,,Genotyping for epidemiology studies,"HEIMBROOK, DAVID","LEIDOS BIOMEDICAL RESEARCH, INC.",MD,"$6,918,585"
Lymphoma,2016,NCI,261200800001E-96-0-36,,Repository Services for epidemiology studies,"HEIMBROOK, DAVID","LEIDOS BIOMEDICAL RESEARCH, INC.",MD,"$1,886,169"
Lymphoma,2016,NCI,261200800001E-96-0-51,,DCTD Biopharmaceutical Development,"HEIMBROOK, DAVID","LEIDOS BIOMEDICAL RESEARCH, INC.",MD,"$6,449,441"
Lymphoma,2016,NCI,261200800001E-96-0-142,,OCG Data Coordinating Center,"HEIMBROOK, DAVID","LEIDOS BIOMEDICAL RESEARCH, INC.",MD,"$540,000"
Lymphoma,2016,NIAID,1R43AI127117-01,,Development of a Small Molecule Inhibitor for EBV Lytic Reactivation,"VAN DEN HEUVEL, PIETER","VIRONIKA, LLC",PA,"$300,001"
Lymphoma,2016,NCI,1R43CA210841-01,,Precision Quality Check of Immunotherapeutics via Single Cell Cytokine Mapping,"ZHOU, JING","ISOPLEXIS, INC.",DE,"$160,286"
Lymphoma,2016,NIAMS,1R43AR070084-01A1,,A multiplex assay for early detection of Cutaneous T-Cell Lymphoma,"BYSTRYAK, SIMON","ALLIED INNOVATIVE SYSTEMS, LLC",NJ,"$219,104"
Lymphoma,2016,NCI,3R44CA159843-03S1,,A new small molecule targeting agent and therapeutic for non-Hodgkin's lymphoma,"BALHORN, RODNEY","SHAL TECHNOLOGIES, INC.",CA,"$94,422"
Lymphoma,2016,NCI,1R21CA210904-01,,Core Essential Genes in Primary Effusion Lymphoma Cell Lines,"GOTTWEIN, EVA",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$201,623"
Lymphoma,2016,NCI,2R01CA163217-06,,Targeted Therapies for HIV-Associated Kaposi Sarcoma and Lymphoma,"DITTMER, DIRK",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$342,759"
Lymphoma,2016,NCI,1R13CA210906-01,,The 19th International Workshop on KSHV and Related Agents,"FENG, PINGHUI",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$5,000"
Lymphoma,2016,NCI,3UM1CA173642-04S1,,Women's Health Initiative Cancer Survivor Cohort,"ANDERSON, GARNET",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$170,764"
Lymphoma,2016,NCI,3R01CA076167-13S1,,Genetic Analysis of Myeloproliferative Disease,"COWELL, JOHN",GEORGIA REGENTS UNIVERSITY,GA,"$106,561"
Lymphoma,2016,NIDCR,1DP5OD023118-01,,Comprehensive analysis of human adaptive immune receptors to elucidate correlates of Epstein-Barr virus disease suppression,"DEKOSKY, BRANDON",UNIVERSITY OF KANSAS LAWRENCE,KS,$1
Lymphoma,2016,RMAP,1DP5OD023118-01,,Comprehensive analysis of human adaptive immune receptors to elucidate correlates of Epstein-Barr virus disease suppression,"DEKOSKY, BRANDON",UNIVERSITY OF KANSAS LAWRENCE,KS,"$369,806"
Lymphoma,2016,NCI,261201100019C-26-0-3,,FT11 NIDDK (WA03),"LYNCH, MARYELLEN",BATTELLE CENTERS/PUB HLTH RES & EVALUATN,OH,"$60,052"
Lymphoma,2016,NCI,1K99CA212198-01,,Dissecting mechanism(s) by which ionizing radiation promotes clonal expansion of premalignant cells in the thymus,"LEE, CHANG LUNG",DUKE UNIVERSITY,NC,"$113,130"
Lymphoma,2016,NCI,1K23CA212271-01,,Novel Strategies to Eliminate Resistance to B-cell Receptor Inhibitor Therapy in Lymphoid Malignancies,"STEPHENS, DEBORAH",UNIVERSITY OF UTAH,UT,"$180,360"
Lymphoma,2016,NCI,1K99CA212276-01,,Role of histone demethylated LSD1 as an epigenetic dependency in lymphoma,"CHATZI, KATERINA",WEILL MEDICAL COLL OF CORNELL UNIV,NY,"$148,904"
Lymphoma,2016,NCI,3R01CA154674-06S1,,Cotranslational Functions of MTOR,"JACINTO, ESTELA",RBHS-ROBERT WOOD JOHNSON MEDICAL SCHOOL,NJ,"$11,768"
Lymphoma,2016,NCI,3R01CA158323-05S1,,Studies of Lymphoma Suppression and DNA Repair,"DU, CHUNYING",UNIVERSITY OF CINCINNATI,OH,"$42,534"
Lymphoma,2016,NHLBI,7R21HL125018-02,,Bispecific cytotoxic lymphocytes in HIV-related lymphoma,"LIU, DONGFANG",METHODIST HOSPITAL RESEARCH INSTITUTE,TX,"$206,832"
Lymphoma,2016,NCI,3UM1CA173642-04S2,,Relationships between guideline-concordant treatment and survival following an endometrial cancer diagnosis in the Life and Longevity After Cancer Study,"ANDERSON, GARNET",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$116,303"
Lymphoma,2016,RMAP,3K01ES025431-04S1,,The role of epigenetic heterogeneity in CLL evolution Admin supplement,"LANDAU, DAN",WEILL MEDICAL COLL OF CORNELL UNIV,NY,"$43,200"
Lymphoma,2016,NCI,1F31CA213871-01,,Investigating the Role of Transcription on DNA Damage at Early Replicating Fragile Sites,"ST GERMAIN, COMMODORE",UNIVERSITY OF CALIFORNIA AT DAVIS,CA,"$35,518"
Lymphoma,2016,NIGMS,3R01GM110052-03S1,,Functional roles of lipids in early B cell receptor signaling SUPPLEMENT,"VEATCH, SARAH",UNIVERSITY OF MICHIGAN,MI,"$150,000"
Lymphoma,2016,RMAP,3R01CA166450-04S2,,Characterizing tumor suppressive functions of microRNAs in B-cell neoplasia,"RAO, DINESH",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$256,667"
Lymphoma,2016,NCI,3P30CA086862-16S1,,Cancer Center Support Grant (CCSG),"WEINER, GEORGE",UNIVERSITY OF IOWA,IA,"$124,694"
Lymphoma,2016,NCATS,NRC15004001-1-0-1,,funding for FY 15/16 Bench-to-Bedside project “CAR-modified CD8+ memory stem cells targeting B-cell malignancies,NO PI IDENTIFIED,NIH,,"$100,000"
Lymphoma,2016,NCI,3R01CA113809-10S1,,Role of Missing Metastasis Gene in tumor progression,"ZHAN, STEVEN",UNIVERSITY OF MARYLAND BALTIMORE,MD,"$54,505"
Lymphoma,2016,NCI,3R35CA197734-01S1,,Targeted Therapy for Leukemia,"BYRD, JOHN",OHIO STATE UNIVERSITY,OH,"$16,280"
Lymphoma,2016,NIAID,4R33AI116205-03,,"Targeting latent HIV-1 Reservoirs with the Antibody-Drug Conjugate, Brentuximab Vedotin","HENRICH, TIMOTHY","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$423,419"
Lymphoma,2016,NCI,3P01CA119070-10S1,,Oncogenic Notch Signaling,"ASTER, JON",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$58,609"
Lymphoma,2016,NCI,3R01CA168482-04S2,,HIV-driven B cell activation: role in the genesis of AIDS-related lymphoma,"MARTINEZ-MAZA, OTONIEL",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$99,797"
Lymphoma,2016,NCI,3R01CA151898-06A1S1,,CRLF2 signaling in B-cell acute lymphoblastic leukemia,"WEINSTOCK, DAVID",DANA-FARBER CANCER INST,MA,"$199,999"
Lymphoma,2016,NCI,3R35CA197734-02S1,,Targeted Therapy for Leukemia,"BYRD, JOHN",OHIO STATE UNIVERSITY,OH,"$65,935"
Lymphoma,2016,NCI,3P50CA126752-10S1,,SPORE in Lymphoma,"HESLOP, HELEN",BAYLOR COLLEGE OF MEDICINE,TX,"$300,703"
Lymphoma,2016,NCI,4R00CA175181-03,,The Role of Viral and Cellular miRNAs in B-cell Lymphomagenesis,"SKALSKY, REBECCA",OREGON HEALTH & SCIENCE UNIVERSITY,OR,"$249,000"
Lymphoma,2016,NCI,3U01CA195568-02S1,,The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study,"CERHAN, JAMES",MAYO CLINIC ROCHESTER,MN,"$45,332"
Lymphoma,2016,NCI,3P30CA086862-16S3,,Cancer Center Support Grant (CCSG),"WEINER, GEORGE",UNIVERSITY OF IOWA,IA,"$400,000"
Lymphoma,2016,NCI,3U01CA195568-02S2,,The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study,"CERHAN, JAMES",MAYO CLINIC ROCHESTER,MN,"$14,960"
Lymphoma,2016,NCI,3R01CA196266-01A1S1,,A Novel Strategy Targeting TfR1 for the Prevention/Treatment of AIDS-related NHL,"PENICHET, MANUEL",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$196,920"
Lymphoma,2016,NCI,3U54CA155496-05S1,,A MULTILEVEL APPROACH TO ENERGY BALANCE AND CANCER ACROSS THE LIFECOURSE,"COLDITZ, GRAHAM",WASHINGTON UNIVERSITY,MO,"$401,250"
Lymphoma,2016,NCI,1ZIACP004410-40,,Family Studies,"TUCKER, MARGARET",NIH,,"$1,014,835"
Lymphoma,2016,NCI,1ZIACP005782-22,,Epidemiology of Oncogenic Viruses,"O'BRIEN, THOMAS",NIH,,"$251,756"
Lymphoma,2016,NCI,1ZIACP010125-21,,Cancer Risk and Environmental Exposures,"WARD, MARY",NIH,,"$1,788,656"
Lymphoma,2016,NCI,1ZIACP010131-21,,Studies of Populations Exposed to Therapeutic Medical Radiation and Other Agents,"MORTON, LINDSAY",NIH,,"$3,331,177"
Lymphoma,2016,NCI,1ZIACP010150-17,,"Infections, immunity, and inflammation in cancer","ENGELS, ERIC",NIH,,"$756,680"
Lymphoma,2016,NCI,1ZIACP010170-16,,Multidisciplinary Studies of Hematopoietic Malignancies,"MORTON, LINDSAY",NIH,,"$525,147"
Lymphoma,2016,NCI,1ZIACP010176-16,,Epidemiology and Natural History of Cancer-Associated Viruses,"MBULAITEYE, SAM",NIH,,"$1,584,716"
Lymphoma,2016,NCI,1ZIACP010183-14,,Descriptive Studies and Record Linkage,"ANDERSON, WILLIAM",NIH,,"$155,385"
Lymphoma,2016,NCI,1ZIACP010212-07,,Molecular mechanisms of infection-related cancer,"RABKIN, CHARLES",NIH,,"$140,651"
Lymphoma,2016,NCI,4P01CA148600-06,5304,CD19-Specific CB T-cell Therapy for Patients with B-cell Malignancies,"DOTTI, GIANPIETRO",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$46,051"
Lymphoma,2016,NCI,1ZIABC008753-34,,Immunotoxin Therapy of Solid and Hematopoietic Tumors:  Preclinical Studies,"PASTAN, IRA",NIH,,"$2,418,418"
Lymphoma,2016,NCI,1ZIABC009287-32,,Cytokines and T Cell Development,"DURUM, SCOTT",NIH,,"$697,925"
Lymphoma,2016,NCI,1ZIABC009405-22,,Regulation of Lymphocyte Proliferation and Replicative Capacity,"HODES, RICHARD",NIH,,"$661,601"
Lymphoma,2016,NCI,1ZIABC010008-21,,The Genetics of Susceptibility to Mouse Plasma Cell Tumors,"MOCK, BEVERLY",NIH,,"$415,450"
Lymphoma,2016,NCI,1ZIABC010304-18,,Biochemical Basis of T Cell Activation,"SAMELSON, LAWRENCE",NIH,,"$2,097,508"
Lymphoma,2016,NCI,1ZIABC010717-11,,Phase I study of bortezomib and DA-EPOCH-R with microarray in DLBCL,"WILSON, WYNDHAM",NIH,,"$156,494"
Lymphoma,2016,NCI,1ZIABC010719-11,,Randomized Phase II study of borteozmib-EPOCH-R in Mantle cell lymphoma,"WILSON, WYNDHAM",NIH,,"$156,494"
Lymphoma,2016,NCI,1ZIABC010728-11,,Phase III Study of R-CHOP v DA-EPOCH-R with microarray,"WILSON, WYNDHAM",NIH,,"$78,247"
Lymphoma,2016,NCI,1ZIABC010747-11,,Characterization of the Expression and Ligands of KIR3DS1,"MCVICAR, DANIEL",NIH,,"$222,125"
Lymphoma,2016,NCI,1ZIABC010885-09,,Study of Tumor Pathogenesis and Development of Therapies for AIDS Malignancies,"YARCHOAN, ROBERT",NIH,,"$640,424"
Lymphoma,2016,NCI,1ZIABC010888-09,,Clinical Trials of Patients with AIDS-Related Malignancies,"YARCHOAN, ROBERT",NIH,,"$667,108"
Lymphoma,2016,NCI,1ZIABC010957-09,,Transplant Models,"GRESS, RONALD",NIH,,"$1,301,254"
Lymphoma,2016,NCI,1ZIABC011006-09,,Molecular diagnosis and outcome prediction in lymphoma,"STAUDT, LOUIS",NIH,,"$936,810"
Lymphoma,2016,NCI,1ZIABC011007-09,,RNA interference-based screens for molecular targets in cancer,"STAUDT, LOUIS",NIH,,"$936,810"
Lymphoma,2016,NCI,1ZIABC011008-09,,Oncogenic mechanisms and molecular targets in lymphoma,"STAUDT, LOUIS",NIH,,"$936,810"
Lymphoma,2016,NCI,1ZIABC011010-09,,Oncogenic mechanisms and molecular targets in myeloma,"STAUDT, LOUIS",NIH,,"$936,810"
Lymphoma,2016,NCI,1ZIABC011065-09,,"Preclinical Testing of HDAC, mTOR and MYC Inhibitors","MOCK, BEVERLY",NIH,,"$571,244"
Lymphoma,2016,NCI,1ZIABC011070-09,,Hematopathology Diagnosis,"JAFFE, ELAINE",NIH,,"$964,476"
Lymphoma,2016,NCI,1ZIABC011219-08,,Combination Gene Therapy and Th1-Th2 Therapy,"FOWLER, DANIEL",NIH,,"$368,054"
Lymphoma,2016,NCI,1ZIABC011354-07,,BCR Signaling in ABC DLBCL,"WILSON, WYNDHAM",NIH,,"$156,494"
Lymphoma,2016,NCI,1ZIABC011374-06,,Allotransplant for DOCK8 deficiency,"HICKSTEIN, DENNIS",NIH,,"$644,605"
Lymphoma,2016,NCI,1ZIABC011413-06,,Autologous T cells Transduced with an Anti-CD19 Chimeric Antigen Receptor,"KOCHENDERFER, JAMES",NIH,,"$244,768"
Lymphoma,2016,NCI,1ZIABC011415-06,,Allogeneic T cells Transduced with an Anti-CD19 Chimeric Antigen Receptor,"KOCHENDERFER, JAMES",NIH,,"$61,191"
Lymphoma,2016,NCI,1ZIABC011417-06,,New Chimeric Antigen Receptors for Treating Hematologic Malignancies,"KOCHENDERFER, JAMES",NIH,,"$367,151"
Lymphoma,2016,NCI,1ZIABC011427-05,,Immunohistochemical analysis of tumors,"MIETTINEN, MARKKU",NIH,,"$1,785,509"
Lymphoma,2016,NCI,1ZIABC011511-04,,Chemical Targeting of Multi-Protein Complexes,"BERNAL, FEDERICO",NIH,,"$158,766"
Lymphoma,2016,NCI,1ZIABC011561-03,,Exploring mechanisms that govern immune homeostasis in skin,"NAGAO, KEISUKE",NIH,,"$1,303,301"
Lymphoma,2016,NCI,1ZIABC011654-02,,TEDDI-R in PCNSL,"WILSON, WYNDHAM",NIH,,"$234,740"
Lymphoma,2016,NCI,1ZIABC011660-02,,Development of fully-human anti-CD30 chimeric antigen receptors,"KOCHENDERFER, JAMES",NIH,,"$183,575"
Lymphoma,2016,NCI,1ZIABC011700-01,,Patient Oriented Research in Viral Malignancies and HIV-associated Cancers,"ULDRICK, THOMAS",NIH,,"$1,114,919"
Lymphoma,2016,NCI,1ZIASC000550-36,,Lymphoma Disease Discovery and Definition,"JAFFE, ELAINE",NIH,,"$843,916"
Lymphoma,2016,NCI,1ZIASC006741-24,,Lymphoma Studies,"WILSON, WYNDHAM",NIH,,"$782,468"
Lymphoma,2016,NCI,1ZIASC010282-19,,Cytogenetic Studies of B-cell Chronic Lymphocytic Leukemia (B-CLL),"ARTHUR, DIANE",NIH,,"$103,414"
Lymphoma,2016,NCI,1ZIASC010288-19,,Th1-Th2 and Tc1-Tc2 T Cell Subsets in Transplantation Therapy,"FOWLER, DANIEL",NIH,,"$736,109"
Lymphoma,2016,NCI,1ZIASC010356-17,,A Role for KSHV in the Pathogenesis of Malignancies,"TOSATO, GIOVANNA",NIH,,"$392,067"
Lymphoma,2016,NCI,1ZIASC010357-17,,Gene Expression and Post-Transcriptional Regulation of DNA Tumor Viruses,"ZHENG, ZHI-MING",NIH,,"$1,268,556"
Lymphoma,2016,NCI,1ZIASC010378-16,,Activation of Proto-Oncogenes by Chromosomal Translocation,"APLAN, PETER",NIH,,"$469,870"
Lymphoma,2016,NCI,1ZICBC011029-09,,Preclinical development and clinical monitoring of adoptive immune therapy,"HAKIM, FRANCES",NIH,,"$643,479"
Lymphoma,2016,NCI,1ZICBC011079-09,,Molecular Diagnostics Core Laboratory,"RAFFELD, MARK",NIH,,"$1,793,683"
Lymphoma,2016,NCI,1ZICBC011093-09,,Flow Cytometric Detection of Malignant Cells in Body Fluids,"STETLER-STEVENSON, MARYALICE",NIH,,"$232,127"
Lymphoma,2016,NCI,1ZIDBC010963-09,,ETIB Clinical Research Core,"GRESS, RONALD",NIH,,"$1,527,560"
Lymphoma,2016,NCI,1ZIDBC010990-09,,Radiation Oncology Branch - Radiation Clinic,"CAMPHAUSEN, KEVIN",NIH,,"$7,464,425"
Lymphoma,2016,NCI,1ZIDBC011317-07,,Dermatology Consultation Service,"COWEN, EDWARD",NIH,,"$528,764"
Lymphoma,2016,NCI,1ZIEBC010843-10,,Medical Oncology Fellowship Program,"BILUSIC, MARIJO",NIH,,"$6,281,232"
Lymphoma,2016,NCI,1ZIEBC011241-08,,Hematopathology Fellowship,"JAFFE, ELAINE",NIH,,"$602,798"
Lymphoma,2016,NCI,1ZIGBC010856-10,,Basic and Preclinical Animal Models in support of Cancer and HIV-AIDS Research,"CUSTER, MARY",NIH,,"$21,493,679"
Lymphoma,2016,NHLBI,1ZIAHL002346-12,,"Tumor microenvironment in CLL and MCL: pathogenesis, targets, and therapy","WIESTNER, ADRIAN",NIH,,"$1,602,982"
Lymphoma,2016,NHLBI,1ZIAHL005076-11,,"Novel therapies for Mantle Cell Lymphoma: targets, mechanisms, and prognosis","WIESTNER, ADRIAN",NIH,,"$228,997"
Lymphoma,2016,NHLBI,1ZIAHL006070-07,,Immunotherapy of low grade lymphoid malignancies,"WIESTNER, ADRIAN",NIH,,"$457,995"
Lymphoma,2016,NCI,3R42CA173900-03S1,,Targeting B-cell lymphoma with Leukothera-phase II,"BELINKA, BENJAMIN","ACTINOBAC BIOMED, INC.",NJ,"$140,000"
Lymphoma,2016,NIAID,1ZIAAI000565-20,,Regulation of SIGNALLING PATHWAYS INVOLVING NUCLEAR FACTOR KAPPA B,"LENARDO, MICHAEL",NIH,,"$296,523"
Lymphoma,2016,NIAID,1ZIAAI000732-22,,"Clinical, Immunological and Genetic  Analyses of ALPS and Related Disordrs","RAO, VEMULKONDA",NIH,,"$273,477"
Lymphoma,2016,NIAID,1ZIAAI000733-22,,Enveloped Virus Glycoprotein/receptor Interactions,"BERGER, EDWARD",NIH,,"$270,599"
Lymphoma,2016,NIAID,1ZIAAI000913-15,,Epstein-Barr Virus Associated Disorders,"COHEN, JEFFREY",NIH,,"$800,033"
Lymphoma,2016,NIAID,1ZIAAI000978-11,,Herpesvirus Pathogenesis and Vaccine Development,"COHEN, JEFFREY",NIH,,"$400,016"
Lymphoma,2016,NIAID,1ZIAAI001024-10,,Molecular Regulation of B-Cell Differentiation and Function,"MORSE, HERBERT",NIH,,"$566,238"
Lymphoma,2016,NCATS,1ZIATR000047-02,,HTS enabled examination of drug combinations,"THOMAS, CRAIG",NIH,,"$147,272"
Lymphoma,2016,NCATS,1ZIATR000249-01,,"Canine models for characterization, diagnosis, and treatment of human cancers using comparative canine-human transcriptomics","TAWA, GREGORY",NIH,,"$248,608"
Lymphoma,2016,NIDDK,1ZIADK036167-10,,Structural studies of the post-cleavage complex in V(D)J recombination,"GELLERT, MARTIN",NIH,,"$2,290,326"
Lymphoma,2016,NIAID,1ZIAAI000858-17,,Lymphomas And Retroviral Pathogenesis,"MORSE, HERBERT",NIH,,"$424,678"
Lymphoma,2016,NIAID,1ZIAAI001187-04,,New Roles of Magnesium as a Regulatory Ion in Immune Responses and Cell Behavior,"LENARDO, MICHAEL",NIH,,"$358,332"
